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The problem of interpreting biological data is often cast into a mathematical
optimization framework where a large body of existing computational theory and
practical techniques can be leveraged. While this strategy has been particularly
successful in the bioinformatics domain, the massive datasets generated by
high-throughput genomic technologies are challenging the scalability of even the
most advanced mathematical optimization algorithms. Indeed, as the cost per base
of of DNA sequencing has dropped precipitously, even outpacing Moore’s law, the
size of many bioinformatics problems has grown beyond the limit of existing
methods, necessitating new algorithms. This effect is felt even more acutely in the
burgeoning field of single cell biology where advances in microfluidics has rapidly
increased the ability of bench biologists to capture and sequence the genomes and
transcriptomes of hundreds of cells per experiment.
This dissertation presents novel computational method for answering three
distinct biological questions: genome scaffolding, biomarker selection, and
computational deconvolution of gene expression data from heterogeneous samples
assisted by single-cell expression data. Each method strives to balance
computational efficiency with the biological relevance of computed solutions.
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Preface
Next-generation sequencing, microarrays and other high-throughput technologies have
generated an enormous amount of biological data. Analysis of these large datasets
poses significant bioinformatics challenges and requires novel algorithms that are accurate and scalable. Further compounding this challenge is the fact that new highthroughput technologies are often error prone. The following body of work explores
the use of scalable optimization algorithms for three distinct bioinformatics problems.
Genome scaffolding. At the core of modern genetics studies is availability of the
genome sequence. There has been much work in developing scalable genome assembly algorithms that are both accurate and capable of working with high-throughput
sequencing data. However it has been observed that extremely high-coverage, at a
higher cost, is necessary to obtain contigs long enough to be biological useful. One
key component of modern genome assembly pipelines is a scaffolding step whereby
assembled contigs are ordered and oriented relative to each other.
Integer linear programming (ILP) is a powerful combinatorial optimization technique that allows modeling and computing optimal solutions of complex real-world
problems. One drawback of this approach is that in the worst-case ILP solvers can
take exponential time. This work presents an ILP based solution to the scaffolding
problem that is both accurate and scalable. Scalability is achieved through the use
of Non-serial Dynamic Programming (NSDP), a technique which exploits the natural
sparsity of the problem to compute the optimal solution in stages.
Biomarker selection. Another classic bioinformatics problem made challenging
due to high-throughput data is the task of building predictive classification models.
There can be thousands to millions of potential features, commonly referred to as
biomarkers. Often a small yet maximally informative subset of biomarkers is desired
due to cost, performance issues, and the desire for simplicity. This problem is known
as feature selection.
Given a biological dataset there exists little a priori justification for choosing
a particular feature selection and classification algorithm. Experience or anecdotal
iv

evidence is often used by bioinformatics researchers to choose an approach to apply
to a dataset. A comprehensive comparative study can explores the efficacy of various
feature selection and classification algorithms on diverse genomic datasets.
When there is missing data, and the data is binary with no replicates then the
problem becomes challenging. This scenario occurs when the features are curated
from literature and in-situ experiments (images). An additional practical challenge
is to identify the most informative markers given physical constraints dictated by
the technology used to interrogate the chosen markers such as the number of wells
available on one qPCR chip. We present an ILP feature selection algorithm that has
comparable performance to leading statistical approaches while keeping the ability to
add real-world constraints.
Single-cell assisted deconvolution. Whole transcriptome expression profiles
captured using high-throughput technologies often come from bulk biological samples
consisting of heterogeneous mixtures of cells. However, in many contexts it would
be beneficial to infer the expression profiles and concentrations of each constituent
cell-type. This problem is known as the gene expression deconvolution problem.
Existing deconvolution approaches often perform poorly when constituent celltypes have highly similar expression profiles, e.g., when attempting to discern between
a progenitor cell and its recent progeny. The development of single-cell resolution
qPCR has allowed for the accurate survey of a small number of genes at the cellular
level. Initial work utilizing a quadratic programming (QP) formulation to exploit
single-cell qPCR data for deconvolution of heterogeneous bulk samples is presented.

v
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Chapter 1
Genome Scaffolding
Interest in de novo genome assembly has been renewed in the past decade due to
rapid advances in high-throughput sequencing (HTS) technologies which generate
relatively short reads resulting in highly fragmented assemblies consisting of contigs.1 Additional long-range linkage information is typically used to orient, order,
and link contigs into larger structures referred to as scaffolds. Due to library preparation artifacts and erroneous mapping of reads originating from repeats, scaffolding
remainings a challenging problem. In this paper, we provide a scalable scaffolding
algorithm (SILP2) employing a maximum likelihood model capturing read mapping
uncertainty and/or non-uniformity of contig coverage which is solved using integer
linear programming. A Non-Serial Dynamic Programming (NSDP) paradigm is applied to render our algorithm useful in the processing of larger mammalian genomes.
To compare scaffolding tools, we employ novel quantitative metrics in addition to the
extant metrics in the field. We have also expanded the set of experiments to include
scaffolding of low-complexity metagenomic samples.
SILP2 achieves better scalability through a more efficient NSDP algorithm than
previous release of SILP. The results show that SILP2 compares favorably to previous
methods OPERA and MIP in both scalability and accuracy for scaffolding single
genomes of up to human size, and significantly outperforms them on scaffolding low1

The results presented in this chapter are based on joint work with H. Salooti, I. Mandoiu and
A. Zelikovsky published in [62].

1

complexity metagenomic samples.
Equipped with NSDP, SILP2 is able to scaffold large mammalian genomes, resulting in the longest and most accurate scaffolds. The ILP formulation for the maximum
likelihood model is shown to be flexible enough to handle metagenomic samples.

1.1

Motivation

De novo genome assembly is one of the best studied problems in bioinformatics.
Interest in the problem has been renewed in the past decade due to rapid advances
in high-throughput sequencing (HTS) technologies, which have orders of magnitude
higher throughput and lower cost compared to classic Sanger sequencing. Indeed,
top-of-the-line instruments from Illumina and Life Technologies are currently able to
generate in a single run billions of reads with an aggregate length of hundreds of
gigabases, at a cost of mere cents per megabase. However, most HTS technologies
generate relatively short reads, significantly increasing the computational difficulty
of the assembly problem. Despite much work on improved assembly algorithms for
HTS shotgun reads [104, 17, 32, 19, 57, 111], de novo assembly remains challenging,
often resulting in highly fragmented assemblies, see [4, 25, 61, 76, 80, 82, 96, 93]
for recent reviews and benchmarking results. For example, the recent Assemblathon
2 community effort to benchmark de novo genome assemblers [4] shows that the
performance of evaluated assemblers is highly variable from dataset to dataset and
generally degrades with the complexity of the sample.
To increase the utility of such fragmented assemblies, additional long-range linkage
information is typically used to orient, order, and link contigs into larger structures
referred to as scaffolds. Although long-range linkage information can be generated
using a variety of technologies, including Sanger sequencing of both ends of cloned
DNA fragments of up to hundreds of kilobases, Pacific Biosciences reads of up to
tens of kilobases [66], and optical maps [77], the most common type of data used in
scaffolding are HTS read pairs generated from DNA fragments with length ranging
between hundreds of bases to tens of kilobases.
2

While HTS read pairs are relatively easy to generate, the linkage information they
provide is noisy due to library preparation artifacts and erroneous mapping of reads
originating from repeats. The general scaffolding problem is known to be computationally NP-hard when linkage data contains errors [46]. Moreover, the associated
contig orientation and contig ordering problems are intractable as well: the orientation problem is equivalent to finding a maximum bipartite subgraph, whereas the
ordering problem is similar to the Optimal Linear Arrangement problem, both of
which are NP-hard [27]. Due to the intractability of the problem, greedy heuristics have been employed in practical scaffolding methods such as[46, 83]. Scaffolding
methods such as SOPRA [21] reduce the size of the problem by iteratively removing
inconsistent links and contigs, while MIP [92] heuristically partitions the biconnected
components of the scaffolding graph when they are too large to scaffold optimally by
mixed integer programming. In SLIQ [89], inequalities are derived from the geometry
of contigs to predict the orientation and ordering of adjacent contigs. To find a feasible solution with minimum read pair inconsistency, OPERA [26] provides a novel
dynamic programming algorithm.
Algorithms based on explicit statistical models are currently gaining popularity
in the area of genome assembly [43], with notable advances in the use of maximum
likelihood (ML) methods for both contig assembly [75] and assembly evaluation [84].
In this paper we introduce a highly scalable algorithm based on likelihood maximization for the scaffolding problem. The key step in our algorithm is the selection of
contig orientations and a set of read pairs consistent with these orientations (and
locally consistent with each other) such that the overall likelihood of selected pairs is
maximized. As in previous works [75, 84], the likelihood model we employ assumes
independence of the HTS read pairs. The currently implemented model takes into
account read mapping uncertainty due to overlap with annotated contig repeats as
well as variations in contig coverage. The model can be easily extended to incorporate sequencing errors and the distribution of insert lengths; currently we only use
the latter to eliminate read pairs with highly discordant insert length lower-bounds
and to compute ML estimates for the final gap lengths. Likelihood maximization is
3

formulated as an integer linear program (ILP). Unlike MIP [92], our ILP formulation
selects contig orientations and a set of locally consistent read pairs but neither explicitly orders the contigs nor fully guarantees global consistency of selected pairs. The
latter are achieved by decomposing the set of selected read pairs into linear paths via
bipartite matching.
Scalability of our algorithm, referred to as SILP2, is achieved by adopting a nonserial dynamical programming (NSDP) approach [100]. Rather than solving one large
ILP, several smaller ILPs can be solved seperatly and composed to find the complete
and optimal solution. The order in which the smaller ILPs are solved is determined
by the 3-connected components of the underlying scaffolding graph, which can be
efficiently identified in linear time via the SPQR-tree data structure [42, 36].
Compared to the preliminary version of the algorithm published in [63], referred
to as SILP1, SILP2 is based on explicit formalization of likelihood maximization as
the optimization objective. We present experiments with several likelihood models
capturing read mapping uncertainty and/or non-uniformity of contig coverage. SILP2
also achieves higher scalability by using a more efficient NSDP algorithm than SILP1.
This greatly reduces the need for heuristics such as the hierarchical scaffolding approach of SILP1, whereby scaffolding is performed by progressively decreasing the
minimum bound on the size of read pair bundles. We have also expanded the set of
experiments to include scaffolding of low-complexity metagenomic samples. The results show that SILP2 compares favorably to previous methods OPERA and MIP in
both scalability and accuracy for scaffolding single genomes of up to human size, and
significantly outperforms them on scaffolding low-complexity metagenomic samples.

1.2

Methods

Given a set of contigs 𝐶 and a set of read pairs 𝑅, the scaffolding problem asks for
the most likely orientation of the contigs along with a partition of the contigs into
ordered sets connected by read pairs of 𝑅. The main steps of the SILP2 algorithm
are as follows (see Figure 1-1 for a high-level flowchart). We first map the read onto
4

contigs using Bowtie2 [54], disregarding pairing information in the mapping process.
Alignments are processed to extract read pairs for which both reads have unique
alignments, and the alignments are onto distinct contigs. A scaffolding graph is then
constructed with nodes corresponding to contigs and edges corresponding to extracted
read pairs. The scaffolding graph is partitioned into 3-connected components using
the SPQR tree data structure [42, 36] implemented in OGDF [20]. The maximumlikelihood contig orientation is formulated as an ILP that is efficiently solved by applying non-serial dynamic programming based the SPQR tree data structure. Next,
scaffold chains are extracted from the ILP solution by using bipartite matching and
breaking remaining cycles. Finally, maximum likelihood estimates for the gap lengths
are obtained using quadratic programming. Below we detail the key steps of the algorithm, including scaffolding graph construction, the maximum likelihood models used
for contig orientation and mapped read pair probability estimation, then we briefly
overview the orientation, the ILP formulation and the improved NSDP algorithm for
efficiently solving the ILP.
Scaffolding graph. The scaffolding problem is modeled with a scaffolding graph
𝐺 = (𝑉, 𝐸), where each node 𝑖 ∈ 𝑉 represents a contig and each edge (𝑖, 𝑗) ∈ 𝐸
represents all read pairs whose two individual reads are mapped to the contigs 𝑖 and
𝑗, respectively. Each read in a pair is aligned either to the forward or reverse strand of
corresponding contig sequence, and this results in 4 possible configurations for a read
pair (denoted A, B, C, or D, see Figure 1-2) which can be modeled as a bidirected
edge [92, 26, 63]. Orientation of contigs and the bidirected orientation of edges should
agree (be concordant) with each other and should not result in any directed cycles
for linear genomes (e.g. eukaryotes).
Maximum likelihood scaffold graph orientation. As an intermediate step
towards solving the scaffolding problem, we consider the problem of determining an
orientation of the scaffolding graph, which includes choosing one of the two possible
orientations for each node (contig) 𝑖 ∈ 𝑉 as well as choosing for each edge (𝑖, 𝑗) ∈ 𝐸
one of the four bidirections that is concordant with the orientations of 𝑖 and 𝑗. A
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Figure 1-1: A flowchart describing the SILP workflow.

common way to reduce an inference problem to an optimization problem is to seek
a feasible solution with maximum likelihood. Let each observation, i.e., aligned read
pair 𝑟 ∈ 𝑅, have a probability 𝑝𝑟 of being correct. Any feasible contig orientation
𝑂 = 𝑂(𝐶) either agrees or disagrees with the read pair 𝑟. Let 𝑅𝑂 be the set of read
pairs agreeing with 𝑂. Assuming independence of observations, the likelihood of an
orientation 𝑂 can be written as
∏︁
𝑟∈𝑅𝑂

𝑝𝑟

∏︁
𝑟∈𝑅−𝑅𝑂

∏︁ (︂ 𝑝𝑟 )︂
(1 − 𝑝𝑟 ) =
(1 − 𝑝𝑘 )
1 − 𝑝𝑟
𝑟∈𝑅
𝑟∈𝑅
∏︁

𝑂
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Figure 1-2: The four possible orientations of a read mate-pair linking two contigs 𝑖
and 𝑗.
and hence its log-likelihood is

∑︀

𝑟∈𝑅

ln(1 − 𝑝𝑟 ) +

∑︀

𝑟∈𝑅𝑂

𝑝𝑟
ln( 1−𝑝
). Since the first sum
𝑟

does not depend on the orientation 𝑂, maximizing the log-likelihood is equivalent to
maximizing
∑︁
𝑟∈𝑅𝑂

(︂
ln

𝑝𝑟
1 − 𝑝𝑟

)︂
(1.1)

over all contig orientations 𝑂.
Mapping probability estimation. If 𝑝𝑟 ’s are assumed to be the same for all
read pairs, then the objective (1.1) reduces to maximization of the number of read
pairs that agree with the contig orientation 𝑂. We consider the following factors that
reduce the probability 𝑝𝑟 that read pair 𝑟 is aligned correctly:
1. Overlap with repeats. As noted above, only pairs for which both reads map
uniquely to the set of contigs are used for scaffolding. Still, a read that fully
or partially overlaps a genomic repeat may be uniquely mapped to the incorrect location in case repeat copies are collapsed. We preprocess contigs to
annotate repeats from known repeat families and by recording the location of
multimapped reads. An estimate of the repeat-based mapping probability 𝑝𝑟𝑒𝑝
𝑟
is found by taking the percentage of bases of 𝑟 aligned to non-repetitive portions
of the contigs.
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2. Contig coverage dissimilarity. Although sequencing coverage can have significant departures from uniformity due to biases introduced in library preparation and sequencing, the average coverage of adjacent contigs is expected to
be similarly affected by such biases (all read alignments, including randomly
allocated non-unique alignments, are used for estimating computing average
contig coverages). If the two reads of 𝑟 map to contigs 𝑖, respectively 𝑗, the
coverage-based mapping probability of 𝑟, 𝑝𝑐𝑜𝑣
𝑟 , is defined as 1 − |𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒𝑖 −
𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒𝑗 |/(𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒𝑖 + 𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒𝑗 ).
Note that factors such as repeat content of the sequenced genome and sequencing
depth will determine how informative repeat-based and coverage-based mapping prob𝑐𝑜𝑣
abilities are. Depending on these factors, either 𝑝𝑟𝑒𝑝
𝑟 , 𝑝𝑟 , or their product may pro-

vide the most accurate estimate for 𝑝𝑟 . Mismatches and indels in read alignments,
that can be caused by sequencing errors or polymorphisms in the sequenced sample,
can easily be incorporated in the estimation of mapping probabilities.
Integer linear program. Our integer linear program maximizes the log-likelihood
of scaffold orientation using the following boolean variables:
– a binary variable 𝑆𝑖 for each contig 𝑖, with 𝑆𝑖 equal to 0 if the contig’s orientation
remains the same and 𝑆𝑖 = 1 if the contig’s orientation is flipped w.r.t. default
orientation in the final scaffold.
– a binary variable 𝑆𝑖𝑗 for each edge (𝑖, 𝑗) ∈ 𝐸, which equals 0 if none or both 𝑖th
and 𝑗th contigs are flipped, and equals 1 if only one of them is flipped.
– binary variables 𝐴𝑖𝑗 (respectively, 𝐵𝑖𝑗 , 𝐶𝑖𝑗 , and 𝐷𝑖𝑗 ) which are set to 1 if and
only if an edge in state 𝐴 (respectively, 𝐵, 𝐶, or 𝐷) is used to connect contigs
𝑖 and 𝑗 (see Figure 1-3). For any contig pair 𝑖 and 𝑗, at most one of these
variables can be one.
𝑟
Let 𝐴𝑟𝑖𝑗 (respectively, 𝐵𝑖𝑗𝑟 , 𝐶𝑖𝑗𝑟 or 𝐷𝑖𝑗
) denote the set of read pairs supporting state 𝐴

(respectively, 𝐵, 𝐶, or 𝐷), between the 𝑖th and 𝑗th contig. Define the constant 𝐴𝑤
𝑖𝑗
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by
𝐴𝑤
𝑖𝑗

=

∑︁

(︂

𝑝𝑟
1 − 𝑝𝑟

ln

𝑟∈𝐴𝑟𝑖𝑗

)︂

𝑤
with 𝐵𝑖𝑗𝑤 , 𝐶𝑖𝑗𝑤 and 𝐷𝑖𝑗
defined analogously.
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Figure 1-3: ILP constraints forbiding 2-cycles.
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Figure 1-4: ILP constraints forbiding 3-cycles.

We now ready to formulate the ILP for maximizing the log-likelihood of a scaffold
orientation:
∑︁

𝑤
𝑤
𝑤
(𝐴𝑤
𝑖𝑗 · 𝐴𝑖𝑗 + 𝐵𝑖𝑗 · 𝐵𝑖𝑗 + 𝐶𝑖𝑗 · 𝐶𝑖𝑗 + 𝐷𝑖𝑗 · 𝐷𝑖𝑗 )

(1.2)

(𝑖,𝑗)∈𝐸

where
𝑆𝑖𝑗 ≤ 𝑆𝑖 + 𝑆𝑗

𝑆𝑖𝑗 ≤ 2 − 𝑆𝑖 − 𝑆𝑗

(1.3)

𝑆𝑖𝑗 ≥ 𝑆𝑗 − 𝑆𝑖

𝑆𝑖𝑗 ≥ 𝑆𝑖 − 𝑆𝑗

(1.4)

𝐵𝑖𝑗 + 𝐶𝑖𝑗 ≤ 𝑆𝑖𝑗

(1.5)

𝐴𝑖𝑗 + 𝐷𝑖𝑗 ≤ 1 − 𝑆𝑖𝑗
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In this ILP, constraints (1.3-1.5) enforce agreement between contig orientation
variables 𝑆𝑖 ’s and edge orientation variables 𝑆𝑖𝑗 ’s, 𝐴𝑖𝑗 ’s, 𝐵𝑖𝑗 ’s, 𝐶𝑖𝑗 ’s, and 𝐷𝑖𝑗 ’s.
Since eukaryotic genomes are linear, a valid scaffold orientation should not contain
any cycles. The constraints (1.5) already forbid 2-cycles. Additionally, 3-cycles are
forbidden with the constraints shown in Figure 1-4. Larger cycles generated in the
ILP solution are broken heuristically because it is infeasible to forbid all of them using
explicit constraints.
Non-serial dynamic programming. For large mammalian genomes, the number of variables and constraints is too large for solving the ILP (1.2)-(1.5) via standard
solvers (SILP2 uses CPLEX[48] which is available free of charge for academic institutions). We adopt the non-serial dynamic programming (NSDP) paradigm to overcome
this barrier and to optimally solve the problem. NSDP is based on the interaction
graph with nodes corresponding to ILP variables and edges corresponding to the ILP
constraints – two nodes are adjacent in the interaction graph if their associated variables appear together in the same constraint. Through the NSDP process, variables
are removed in the way that adjacent vertices can be merged together [100]. The first
step in NSDP is identifying weakly connected components of the interaction graph.
We find the 2- and 3-connected components of the interaction graph with efficient
algorithms and then we solve each component independently in such a way that the
solutions can be merged together to find the global solution.
All constraints (1.3-1.5) as well 3-cycle constraints connect 𝑆𝑖 ’s following the edges
of the scaffolding graph. Therefore, the 𝑆𝑖 -nodes of the interaction graph for our ILP
will have the same connectivity structure as the scaffolding graph 𝐺 = (𝑉, 𝐸). As it
has been noticed in [26], the scaffolding graph is a bounded-width graph and should be
well decomposable in 2- and 3-connected components. The SPQR-tree data structure
is employed to determine the decomposition order for 3-connected components the
scaffolding graph [42]. The solution to each component of the scaffolding graph is
found using a bottom up traversal through which each component is solved 2 times:
for similar and opposite orientations of the common nodes. The objective value of
each case is then entered into the objective of the parental component. Having the
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solution of all components, top down DFS starting from the same root is performed
to apply the chosen solution for each component.
Below we illustrate the way how the solution is computed in stages through each of
which the results of the previous stage are combined to dynamically solve the problem.
Obviously, an isolated connected component will not influence other components.
Moreover, it has been shown in [92] that 2-connected components can be solved
independently. As it can be seen in Figure 1-5(a), after removing the articulation
point (1-cut) to decompose the graph into 2-connected components, each component
is solved with the same arbitrary direction assigned to the common node, and then the
resulting solutions are collapsed into the parent solution. The pre-assigned direction
will never affect the parent solution since all contigs in the scaffold can be flipped at
the same time.
Still, 2-connected components can be very large, so we look for 2-cuts in order
to decompose the graph into significantly smaller 3-connected components. Figure
1-5(b) shows that splitting the two 2-cut nodes 𝑖 and 𝑗 decomposes the graph into
3-connected components A and B. The ILP for component A is solved twice to obtain
(1) the ILP solution 𝑠𝑜𝑙00 in which the 2-cut nodes 𝑖 and 𝑗 are constrained to both
have default orientations;
(2) the ILP solution 𝑠𝑜𝑙01 in which the 2-cut nodes 𝑖 and 𝑗 are constrained to have
opposite orientations.
The two solutions are combined to solve the ILP for component B. The ILP objective
for component B should be updated by adding the term of 𝑠𝑜𝑙00 +(𝑠𝑜𝑙01 -𝑠𝑜𝑙00 ) · 𝑆𝑖𝑗 or,
𝑤
equivalently, the value 𝑠𝑜𝑙00 should be added to 𝐴𝑤
𝑖𝑗 and 𝐷𝑖𝑗 and the value 𝑠𝑜𝑙01 should

be added to 𝐵𝑖𝑗𝑤 and 𝐶𝑖𝑗𝑤 . The overall solution is obtained by identifying the common
nodes of the components. In the example on Figure 1-5(b), the optimal solution
happens when 2-cut nodes have opposite directions. The corresponding solution of
ILP for the component A should be incorporated in the overall solution. When the
scaffolding graph has 3-connected components too large to handle, 3-cuts could also
be used for decomposition.
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Figure 1-5: (a) Graph decomposition into 2-connected components: Red (1-cut)
node splits the graph into two 2-connected components A and B. The ILP is solved
for each component separately. If the direction of the cut node in the ILP solution
for B is opposite to the one in the solution for A, then the solution of B is inverted.
Then ILP solutions for A and B are collapsed into the parent solution. (b) Graph
decomposition into two 3-connected components: Red and yellow (2-cut) nodes split
the graph into two 3-connected components A and B. The ILP is solved for component
A twice – for the same and the opposite directions assigned to two 2-cut nodes. Then
these two solutions are used in the objective for the ILP of component B. Finally,
ILP solutions for A and B are collapsed into the parent solution.
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The pseudo-code of the SILP2 NSDP algorithm for processing 3-connected components is given in Figure 1-5. SILP2 is different from SILP1 in the else clause –
instead of solving ILP for each of four possible combinations of assignments for 𝑆𝑖
and 𝑆𝑗 as in SILP1, ILP is solved only two times for combinations 𝑆𝑖 = 0 & 𝑆𝑗 = 0
and 𝑆𝑖 = 0 & 𝑆𝑗 = 1.
Thinning Heuristic. Unfortunatly the largest tri-connected component may
still induce an ILP too large for CPLEX to solve in a reasonable amount of time.
In order to address this problem a thinning heuristic is applied to the scaffolding
graph. This scenario can be detected by setting a threshold on the maximum number
of contigs allowed in a tri-connected component. When a component exceeds the
threshold the number of read pairs necessary to induce an edge is increased by one
and decomposition recomputed until there is no component above the threshold.

1.3
1.3.1

Results and Discussion
Datasets and Quality Measures

In order to asses the quality and scalability of our scaffolding tool we developed a
testing framework which closely mimics real world scaffolding problems. We utilized
the Staphylococcus aureus (staph), Rhodobacter sphaeroides (rhodo) genomes and
chromosome 14 of HapMap individual NA12878 (chr14) from the GAGE [93] assembly
comparison. Finally, in a test case designed to stress scalability, contigs from a draft
assembly of individual NA12878 (NA) created by [103] were scaffolded using shortread data.
In all test cases the read pairs used for scaffolding are aligned against the contigs
using bowtie2 [54]. Each read in a pair was required to be aligned uniquely according
to the default scoring scheme, for the pair to be considered valid. Each scaffolder was
given the same set of valid read pairs. Two of the leading external scaffolding tools
MIP [92] and OPERA [26] are used in this comparison. Although many other tools
do exist, these two are widely utilized and actively maintained.
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The three small test cases are used to test both correctness and scalability of
the scaffolding tool. In order to test correctness, contigs simulating a draft assembly
were created by placing gaps in the genome. The contig and gap sizes were sampled
uniformly at random from the collection of all the assemblies used in the GAGE
comparison. The procedure to generate the contigs was to alternatively sample with
replacement from the set of all contig sizes, and gap sizes. In this way a simulated
scaffold can be generated so that the position and relative orientation of all contigs
and all gap sizes are known. The orientation of the simulated contigs was randomized
to prevent biases.
For each genome 10 replicates were created, all subsequent results are the average of the 10 replicates. By creating simulated contigs with no assembly error, the
accuracy of subsequent scaffolds can be evaluated exactly. Although the contigs were
simulated, real read pairs were aligned against them and used as input. Table S1 in
Additional File 1 describes the characteristics of each dataset.
The NA12878 test case was produced by simply using the contigs created in the
SGA [103] assembler publication. The read pairs were obtained from a different lab,
however they were generated using the same biological source material (ERP002490).
Although more read pairs were available a random subset of approximately 2x coverage was used.
Finally a simulated metagenomics test case was created to explore the feasibility
of utilizing SILP2 to scaffold metagenomes. This was created by artificially mixing
the staph and rhodo contigs and reads at varying proportions.
A natural and common parameter present in all scaffolding algorithms in the bundle size, or the number of read pairs spanning two contigs. This parameter is a natural
control of sensitivity and specificity; requiring more support increases specificity at
the price of sensitivity and vice-versa. It should be noted that every scaffolding
tool tested, including SILP2 does not abide by the set parameter absolutely. Each
method raises it in order to ensure efficient operation. The simulated test cases were
evaluated at several bundle sizes to asses its effect on accuracy and scalability. The
NA12878 test case was only evaluated at the minimum feasible value due to resource
14

constraints.

1.3.2

Accuracy

Calculating the accuracy of de novo assemblies or scaffolds is quite difficult. One of
the key challenges is deciding on the appropriate measure. In this comparison we
elect to present several metrics which will likely have different weight depending on
the background and intention of the reader.
For the simulated contigs we treat scaffolding as a binary classification problem
where methods attempt to predict true adjacencies in the test dataset. The accuracy
and sensitivity can be directly measured by computing true positive, and false positive rates. One common summary is MCC, or Mathews Correlation coefficient. This
measure assess sensitivity and specificity simultaneously. In the context of scaffolding, this measure illustrates how many correctly ordered and oriented scaffolds were
created.
An alternative measure, commonly utilized in genome assembly comparison publications [93, 35] is the notion of corrected N50. Where N50 is the weighted mean
scaffold size, the corrected N50 is the same statistic after errors are removed. This can
be computed exactly on simulated data, however an alignment based approximation
must be used on real test cases.
Finally the usefulness of a genome can also be measured by the number of identifiable biological features captured. Here we capture this measure by recording the
percentage of known genes that are found contiguous in the scaffolds.

MCC
The MCC metric, as seen in Figure 1-6, indicates that SILP2 is able to correctly join
the most contigs, followed by OPERA and finally MIP. This order holds for all three
simulated test cases. Interestingly all three methods see a decrease in MCC on staph,
but some have increases on rhodo and chr14. This trend illustrates the difficult to
define variables such as genome uniqueness, assembly and read error which can make
15

Figure 1-6: MCC for SILP2, OPERA and MIP across bundle sizes and all three
simulated assemblies staph, rhodo, chr14. Note at bundle size 1 for chr14 OPERA
exceeded the allowed runtime of 2 days and did not complete.
smaller genomes more challenging that larger genomes.
While MCC is natural to a computer scientist its useful to a biologist is lacking
because the content of the contigs is ignored. A biologist typically asses a scaffold
by the N50, Unfortunately this measure does not reflect the accuracy of the scaffolds
and rewards aggressive merging. Using MCC or its constituent components as metrics
gives greater clarity to the researcher comparing different tools.

N50
The most common metric found in genome assembly and scaffolding is N50. The most
recent iteration of benchmark projects have transformed this descriptive number into
an accuracy measure by introducing alignment based corrections. Here the scaffolds
are aligned against a reference and miss-alignments are interpreted as orientation, or
placement errors. We have developed a more efficient implementation of the correcting
method developed by [35]. This enables the tool to be utilized on the NA12878 test
16

case at the cost of accuracy.
The true N50 value can be determined when using simulated contigs by breaking incorrect scaffolds, this measure is denoted as TPN50. An analog to the TPN50
measure can be obtained by aligning the scaffolds against the known reference. Scaffolds (and contigs) are broken at mis-assembled or mis-scaffolded regions. This postalignment metrics can be obtained from the assembly evaluation tool called QUAST
[35] and it is denoted as NA50.
Unfortunately the implementation of QUAST required more than 128GB of RAM
to evaluate the NA12878 test case, and therefore could not be run. We wrote an
alternative implementation of NA50 called ALN50 which is more efficient, but follows
a similar framework. Both NA50 and ALN50 are found in Figure 1-7. Although
NA50 and ALN50 do not agree, they do indicate similar trends between methods.
Therefore ALN50 will be used henceforth. In the staph genome, OPERA is clearly
the best performing tool, followed by SILP2 and then MIP. However on the rhodo
genome, SILP2 performs best, followed by OPERA then MIP.
First the highest ALN50 is always found at bundle size 3 or 5. If the intent of the
assembly is to maximize N50 then clearly no algorithm should be run with bundle
size less than 3. However, as it was pointed out in both GAGE and QUAST [35, 93],
N50 is a misleading metric and alternative measures may be a better judge.
Additionally it can be seen that both OPERA and SILP2 have approximately the
same TPN50 in the staph and chr14 test cases, however in rhodo, SILP2 clearly outperforms OPERA and MIP at all bundle sizes. It is not clear why SILP2 performs
much better on rhodo, and approximately equivalent on the others.
For the complete genome SILP2, OPERA and MIP reported an N50 of 26,235,
39,366, 26,235 respectively. This is consistent with the observations from the synthetic
data sets.

Gene Reconstruction
An alternative measure of the completeness of a scaffold is the number of genes
aligned against the scaffold. For a given percentage of completeness the number of
17
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Figure 1-7: TPN50 is obtained by breaking incorrect scaffolds, ALN50 is the postalignment metric developed by us, and NA50 is the QUAST equivalent. The colors
indicated in the legend correspond to the bundle size 1 through 7. OPERA was
unable to complete on bundle size 1 for chr14 dataset.
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Table 1.1: In order for a gene to be considered reconstructed 90% of its sequence
must be found in a contiguous scaffold. Dashes (-) indicate the method was unable
to complete and therefore the gene count could not be computed.
genome bundle
1
2
staph
3
5
7
1
2
rhodo
3
5
7
1
2
chr14
3
5
7
1
NA12878 2x
2

SILP2 OPERA
1,727.70
1,168.50
1,727.70
1,168.50
1,727.70
1,210.60
1,727.70
1,262.70
1,727.40
1,280.40
2022.7
1618.6
2022.7
1618.6
2022.6
1751.1
2022.6
1834.2
2022.6
1853.3
350.9
352.00
330.10
352.40
336.90
352.40
337.50
352.40
337.60
30817
30850
30809

MIP total
1,545.00
1,559.50
1,575.30 2692
1,584.60
1,588.50
1897.3
1907
1894 3067
1921.3
1933.3
349.6
350.40
350.40
529
351.70
3.00
30817
34039
30849

genes found in the corrected scaffold is an indicator of the usefulness of the genome.
As seen in Table 1.1, SILP2 almost consistently equals or outperforms both
OPERA and MIP at all bundle sizes and for each genome. The difference between
SILP2 and MIP is often quite small.
Runtime
One key advantage of SILP2 over other scaffolding tools is its speed and scalability.
Table 1.2 gives the runtime of SILP1, SILP2, OPERA and MIP on single-genome
testcases. All experiments were conducted on a Dell PowerEdge R815 server with
quad 2.5GHz 16-core AMD Opteron 6380 processors and 256Gb RAM running under
Ubuntu 12.04 LTS. IBM ILOG CPLEX 12.5.0.0 was used as ILP solver through
the CPLEX Python API. Reported runtimes are only for the scaffolding portion of
each program. Read alignment and pre-processing steps are not included, but it was
observed that all methods had comparable pre-processing times.
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Table 1.2: All timing was captured only during the scaffolding phase of each tool, all
read alignment and formatting procedures were excluded from timing. The number
is the average of 10 runs for each genome. A dash (-) indicated the tool was unable to
complete in the allotted time of 2 days for staph,rhodo,chr14 and 3 days for NA12878.
genome bundle SILP1 SILP2 OPERA
MIP
1
1237
6.4
2538.1
35.8
2
738
4.5
1456.5
17
staph
3
305
4
878.5 12.834
5
142
3.9
386.9
10.54
7
51
4.3
241 10.115
1
1134
10
2297 118.953
2
632
4.1
455.2
25.3
rhodo
3
486
3.6
5.7 10.995
5
86
3.4
2
8.778
7
75
3
1.6
8.217
1
64.7
706.3
2
27.6
99.25 189.685
chr14
3
629
25.5
11 137.67
5
370
21.5
12 107.85
7
400
19.25
10.75 94.9875
1
55.2
89.3
2
1670
76.49
53.28
NA12878 2x
3
37751
3878
7875 121.61
5
27341
3183
4270
134.6
7
27470
3626
2180 125.66

On the staph, rhodo and chr14 datasets, it was observed that SILP2 was quicker
at higher bundle sizes and no worse than OPERA or MIP at lower bundle sizes. The
NA12878 testcase was extremely challenging for all methods and demonstrated the
effect of heuristics on large test cases. It is clear from the reduced runtimes that all 3
methods activate some sort of heuristic at lower bundle sizes. The difference between
SILP1 and SILP2 is evident at all bundle sizes.
The NA12878 genome was also scaffolded by SILP2 using 20x coverage reads, with
a runtime of 18,205 seconds at bundle size 1. Negligable improvement in accuracy
over the 2x dataset was observed. From Table 1.2 it is clear that runtime increases
with the complexity of the genome more so than the number of read pairs.
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1.3.3

Metagenomics

Metagenomics is the study of genetic material recovered from heterogeneous mixtures
often found in nature. Just like in the de novo assembly of a single genome, the
accuracy and size of the scaffolds is critical to subsequent analysis steps. Our ILP
based solution is flexible enough to include new constraints and objectives to better
serve this challenging scenario.
In order to test this hypothesis a simulated metagenomic dataset was created
utilizing the staph and rhodo genomes from the GAGE dataset. The simulated contigs
used previously were mixed, and both sets of reads were aligned with varying fractions
(1.0, 9.5 0.25, 0.0) of staph reads present.
Again all three of the major scaffolding tools were tested, however additional
weighting scenarios were implemented in SILP2.
The runtime, MCC, SCFN50, TPN50 and ALN50 metrics are detailed for each of
the compared methods in Table 1.3. Also an additional scaffolding tool BAMBUS2
[52] was added to the comparison because it was previously shown to work well in
the metagenomic scaffolding context.
Interestingly all SILP2 variants fare much better than both OPERA, MIP and
BAMBUS2 even with no staph reads present (this differs from results in Figure 1-7
because the rhodo reads were aligned to both staph and rhodo contigs). It is unclear
is the different methodology used in SILP2 sets it apart, or if an implementation quirk
throws off the other scaffolders. However across all metrics SILP2 variants perform
the best.
In both SILP2 variants and MIP it is observed that the TPN50 decreases as
fewer staph reads are utilized. This is expected since there are fewer opportunities to
connect staph contigs and both staph and rhodo contigs are used in the calculation
of N50. There is no major differences between the variants of SILP2. The coverage
based weight seems to improve MCC at the cost of a slightly lowered TPN50 when
compared to no weights.
This highly simplified test scenario is not designed to fully explore metagenomic
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scaffolding, rather to point out an opportunity to further external genome scaffolding
algorithms.

1.4

Conclusions

Scaffolding in an important step in the de novo assembly pipeline. Biologists rely on
an accurate scaffold to perform many types of analysis. The larger the scaffold the
more useful it will be to them. Recent advances in de novo assemblers has made it
feasible to create draft assemblies for large mammalian genomes. We believe that
SILP2, coupled with the most recent scalable assemblers will produce the largest and
most complete assemblies. This is made possible utilizing non-serial dynamic programming approach to solve our robust ILP. The ILP formulation for the maximum
likelihood model is shown to be flexible enough to handle metagenomic samples.
The future work includes more thorough experimental validation of SILP2 and
comparison BAMBUS2 [52] on metagenomic samples. Also we are going to validate
SILP2 using the methodology and benchmarks from the recently published comparative study [45].
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Table 1.3: The second column indicates the percentage of total read pairs used from
the staph genome testcase, all of the rhodo pairs were used. SCFN50 is the uncorrected N50 reported by each scaffolding tool. The N50 of the contigs alone is
10,339bp. The integer appended to SILP2 indicates the bundle weight; 0: none, 1:
coverage, 2: repeat, 3:coverage * repeat. All methods were run at bundle size 1, the
reported number is the average of 10 runs except for OPERA where 6 of the test
cases exceeded runtime limits. TPN50 and MCC were unable to be computed for
BAMBUS2 because the generated AGP had a non-standard format.
METHOD FRAC STAPH RUNTIME SCFN50 ALN50 TPN50 MCC
SILP2_0
1.00
14.3 51,775.0 20,647 34,495
67.6
SILP2_0
0.50
13.3 50,450.0 20,103 36,356
69.1
SILP2_0
0.25
12.7 47,731.0 20,761 35,323
69.3
SILP2_0
0.00
11.5 21,753.0 13,948 15,649
39.9
SILP2_1
1.00
14.3 52,557.0 20,655 33,683
67.5
SILP2_1
0.50
13.8 48,701.0 20,337 35,750
69.0
SILP2_1
0.25
13.4 49,766.0 20,752 35,146
69.0
SILP2_1
0.00
11.0 21,925.0 13,847 15,511
39.3
SILP2_2
1.00
14.3 43,144.0 20,631 31,160
66.3
SILP2_2
0.50
13.5 42,244.0 20,198 32,477
67.5
SILP2_2
0.25
13.2 45,137.0 21,161 31,562
67.6
SILP2_2
0.00
10.8 22,190.0 13,813 16,205
41.6
SILP2_3
1.00
14.1 43,646.0 19,998 28,856
65.3
SILP2_3
0.50
13.2 41,893.0 19,790 30,504
66.6
SILP2_3
0.25
13.0 42,188.0 19,945 30,449
66.4
SILP2_3
0.00
11.5 21,820.0 13,781 15,635
40.0
OPERA
1.00
2247.2 15,573.0 13,082 10,386
10.1
OPERA
0.50
1567.6 13,928.0 12,006 10,440
10.7
OPERA
0.25
884.0 14,786.0 12,617 10,507
10.5
OPERA
0.00
544.3 11,121.0 10,720 10,273
4.9
MIP
1.00
129.9 20,104.0 12,861 18,672
18.4
MIP
0.50
121.3 19,807.0 12,488 17,613
17.4
MIP
0.25
114.0 18,520.0 12,269 16,680
17.2
MIP
0.00
114.1 12,690.0 10,894 12,434
8.7
BAMBUS2
1.00
1025.89 11,251.0 11,238
BAMBUS2
0.50
1452.75 10,781.0 10,822
BAMBUS2
0.25
1676.75 10,806.0 10,834
BAMBUS2
0.00
2272 11,526.0 11,698
-

23

24

Chapter 2
Biomarker Selection and Predictive
Modeling
There is an ever-expanding range of technologies that generate very large numbers
of biomarkers for research and clinical applications.1 Choosing the most informative
biomarkers from a high-dimensional data set, combined with identifying the most
reliable and accurate classification algorithms to use with that biomarker set, can be
a daunting task. Existing surveys of feature selection and classification algorithms
typically focus on a single data type, such as gene expression micro-arrays, and rarely
explore the model’s performance across multiple biological data types.
This paper presents the results of a large scale empirical study whereby a large
number of popular feature selection and classification algorithms are used to identify
the tissue of origin for the NCI-60 cancer cell lines. A computational pipeline was
implemented to optimally tune and evaluate the performance of each pair of feature
selection and classification methods on five different data types available for the NCI60 cell lines in models exploiting both large and small numbers of biomarkers.
As expected, the data type and number of biomarkers have a significant effect on
the performance of the predictive models. Although no model or data type uniformly
outperforms the others across the entire range of tested numbers of markers, several
1

The results presented in this chapter are based on joint work with E. Hemphill, C. Lee, I.I.
Mandoiu, and C.E. Nelson published in [40].
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clear trends are visible. At low numbers of biomarkers gene and protein expression
data types are able to differentiate between cancer cell lines significantly better than
the other three data types, namely SNP, array comparative genome hybridization
(aCGH), and microRNA data. Interestingly, as the number of selected biomarkers
increases best performing classifiers based on SNP data match or slightly outperform
those based on gene and protein expression, while those based on aCGH and microRNA data continue to perform the worst. It is observed that one class of feature
selection and classifier are consistently top performers across data types and number
of markers, suggesting that well performing feature-selection/classifier pairings are
likely to be robust in biological classification problems regardless of the data type
used in the analysis.

2.1

Motivation

Due to the recent rise of big-data in biology, predictive models based on small panels
of biomarkers are becoming increasingly important in clinical, translational and basic
biomedical research. In clinical applications such predictive models are increasingly
being used for diagnosis [1], patient stratification [44], prognosis [79], and treatment
response, among others.
Many types of biological data can be used to identify informative biomarker panels.
Common ones include micro-array based gene expression, microRNA, genomic copy
number, and SNP data, but the rise of new technologies including high-throughput
transcriptome sequencing (RNA-Seq) and mass spectrometry will continue to increase
the diversity of biomarker types readily available for biomarker mining.
Useful predictive models are typically restricted to use a small number of biomarkers that can be cost-effectively assayed in the lab [23]. The use of few biomarkers also
reduces the effects of over-fitting, particularly for limited amounts of training data
[72]. Once training data has been collected and appropriate procedures for normalization of primary data have been defined, assembling a robust biomarker panel requires
the solution of two main computational problems: feature selection, to identify a short
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list of informative biomarkers, and classification, used to make predictions for new
samples based on patterns extracted from the training data. Both of these steps have
been explored extensively in the statistics and machine learning literature, and many
alternative algorithms are available for each. Due to the sheer number of available
choices and the lack of predictable interactions between feature selection method,
classification algorithm, and data type, assembling the most robust biomarker assay
for a given biomedical application is rarely undertaken systematically. Rather, it is
more often driven by the intuition and a priori preferences of the statistician.
Available feature selection methods can be grouped into three broad categories:
filter, wrapper and embedded. Filtering approaches use an easy to calculate metric
which allows quick ranking of the features, with top ranking features being selected.
Wrapper methods use a classification algorithm to interrogate the effect of various
biomarker subsets. Embedded approaches are classification algorithms which eliminate features as part of the training process. Recent studies [39, 53, 55] investigated
the influence of feature selection algorithms on the performance of predictive models and provided a framework for thorough comparison of approaches. However the
effect of the number of biomarkers selected and high-dimensional data type was not
explored.
There are hundreds of publications describing classification algorithms and their
applications to genetic research and medicine. Many publications advocating a new
method employ a limited comparison between similar approaches. However nonuniform validation strategies make it difficult to assess performance of a wide variety
of approaches. A previous study compared both classification and feature selection
approaches in a unified framework [55], however the effect of biological data type was
not explored, but it was observed that the biological question does have an effect on
the best model. Additionally most comparisons typically overlook the effect of model
parametrization even though the choice of parameters can have profound effects on
performance.
This work presents a large scale empirical comparison of the effects of the the interaction between the main components of the predictive model (i.e., feature selection
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and classification algorithms), the number of features utilized, and the underlying data
type on the performance of the overall model. This study also implements exhaustive
parametrization of all models to ensure a fair comparison between models.
In order to test the performance of the large number of models tested in this study,
and in order to be able to run direct comparisons of the models on different biological
data types, we took advantage of the publicly available NCI-60 cancer cell line data
set [85]. The NCI-60 cell line collection represents a carefully curated collection of
60 independent cancer cell lines derived from nine types of cancer occurring in 60
individual patients. Each line has been uniformly cultured and DNA fingerprinted
to ensure independence [67]. In addition, the NCI-60 cell lines have been subjected
to extensive molecular characterization including mRNA microarray [99], microRNA
[31], protein lysate arrays [99], SNP arrays [94], and aCGH analysis [109]. For these
reasons, the NCI-60 data set represents a tremendous research tool for exploring and
benchmarking Omics-type approaches to cancer classification and therapeutics.
Cancers are widely believed to derive from a single event in which one cell escapes the many surveillance mechanisms in place to prevent uncontrolled proliferation. Once this has occurred, the cancer often evolves quickly, rapidly acquiring large
numbers of mutations, ranging from small point mutations to very large chromosomal
aberrations and regional amplifications (DNA duplications). The original identity of
the cancer cell (its cell type or tissue type) appears to exert a very strong influence
on the course of evolution of the cancer. For this reason, characteristic mutations will
often be found in cancers derived from the same tissue, even in different patients. In
addition, because identical cell types from different patients will share very similar
gene expression signatures, cancers derived from these tissues will often do the same.
In the present study we take advantage of these two features of cancer to test the ability of various statistical models to correctly infer the cell type (or “tissue-of-origin”) of
each cancer cell line. The ability to make this inference correctly not only represents
an excellent test of these models on real biological data, it is a good example of the
type of classification ability required for targeted cancer therapeutics.
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2.1.1

Feature selection without replicates

In certain scenarious the biological dataset may contain no replicates, missing observation and binary information. A new feature selection approach utilizing a robust
ILP that is designed to work with manually curated cell type specific expression data
from the Stem Cell Lineage Database [41]. Also this particular data type has a lineage
or hierarchy defined based on the development of each cell type. Therefore this work
introduces a modified accuracy measure that is better suited for this scenario.
Typical notation for the biomarker selection problem is, given 𝑛 cell types with
associated 𝑝-marker expression profiles, it is desirable to find a subset of markers
that allows us to distinguish one cell type from another. This can be regarded as
a supervised feature selection problem [37], where each cell type forms a class of
one instance and the goal is to find a subset of markers achieving high classification
accuracy. However, due to the sparseness of the expression data in this context,
standard feature selection algorithms are not applicable. Let 𝐸 = (𝐸𝑖𝑗 ) be the 𝑛 × 𝑝
expression matrix where 𝐸𝑖𝑗 ∈ {−1, 0, 1} and -1,0,1 denote that marker 𝑗 is absent,
unknown or present in cell type 𝑖 respectively. We denote by 𝐷𝑗 (𝑖1 , 𝑖2 ) the distance
between cell types 𝑖1 and 𝑖2 indexed by marker 𝑗. The distance is 0 if marker 𝑖1 or 𝑖2
is unknown or the expression is the same, 1 otherwise.

This problem is very similar to the classical minimum set covering problem (MSCP)
[78]. In the context of the MSCP, there are 𝑝 sets and set 𝑆𝑗 = {(𝑖1 , 𝑖2 )|𝑖1 <
𝑖2 and 𝐷𝑗 (𝑖1 , 𝑖2 ) = 1}. The goal is to find a smallest collection of sets, 𝐶, such
⋃︀
that 𝑆∈𝐶 𝑆 = {(𝑖1 , 𝑖2 )|𝑖1 < 𝑖2 }. Table 2.1 shows an example 3-marker expression
profiles of 4 cell types. Based on this expression matrix, the 3 sets are listed in table
2.2, where 1 (0) denotes presence (absence) of a pair in a set. Set 𝑆𝑖 contains cell
type pairs that are separable by marker 𝑖. We can see that 𝑆1 , 𝑆2 and 𝑆2 , 𝑆3 are two
smallest collections of sets covering all the pairs. Although MSCP is known to be
NP-hard [50], it is still feasible to find an exact solution to this problem using ILP
since the number of informative markers will be small.
The size of the chosen subset, denoted by 𝜃, is typically not fixed a priori. However
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Cell Type
1
2
3
4

Marker
1 2 3
1 1 0
0 -1 0
1 1 0
0 0 1

Table 2.1: Example marker profile for 4 cell types and 3 markers. Typically 1 is
present, -1 absent and 0 is unknown.

Cell Type Pair
(1, 2)
(1, 3)
(1, 4)
(2, 3)
(2, 4)
(3, 4)

Set
S1
1
0
1
1
0
1

S2 S3
1
0
1
0
1
1
1
0
1
1
0
1

Table 2.2: The sets induced by table 2.1

it is assumed that the size of 𝜃 is directly correlated to the cost of the resulting assay.
Therefore not only should the subset 𝑡ℎ𝑒𝑡𝑎 be maximally informative it should also
have minimal size and therefore cost. Typically the actual number of biomarkers are
fixed to certain sizes dictated by the physical format of the assay.
Finally while many biological questions are binary, or two-class, the prevalence
and relatively low cost of obtaining of high-throughput data has allowed for much
more complex questions to be asked. In the developmental context being explored
here there can be dozens of classes, which actually fall into a hierarchy. Typical
accuracy metrics such as the area under the receiver operator curve (AUROC) do
not utilize the hierarchical structure available. Intuitively miss classifying a sample
as its developmental neighbor should be penalized less than if it were classified in a
completely different lineage. Therefore this work explores a modification of AUROC
that is more appropriate when a cell type lineage is available.
30

2.2

Methods

NCI-60 cancer cell-line dataset
In order to test the predictive models in this study we use publicly available data
from the NCI-60 cancer cell lines as provided by CellMiner [85]. For the purpose of
this study, we analyzed cancers with at least 5 representative cell lines derived from
the same tissue-of-origin (5-9 cell lines per tissue-of-origin). These lines represent
cancers emerging from eight tissues: breast, central nervous system, colon, leukemia,
melanoma, non-small cell lung, ovarian, and renal cancers. The data types used in this
study are gene expression (mRNA) and protein lysate (protein) arrays [99], microRNA
[31], SNP arrays [94], and array comparative genome hybridization (aCGH) [109]. All
data has been normalized according to best practices for each assay platform prior
to downloading for this study [85]. The specific cell lines and data files used in this
study can be found in Tables 2.6 and 2.7.

Feature selection methods
The area of feature selection in machine learning has recently been quite robust.
There are numerous specialized feature selection algorithms which identify the most
informative biomarkers from high-dimensional data. This study utilized at least one
approach from each of the three broad categories identified above (filter, wrapper,
and embedded). Every approach utilized allowed for a specific number of features
to be chosen. No requirement was established that induced a relationship between
feature sets from the same algorithm. So the 16 features chosen by one approach are
not required to be a subset of the 32 features chosen by the same. For all algorithms
we used the implementations in the Scikit-learn [81] Python package, please refer to
its associated documentation for specific implementation details.
The fastest and most simplistic selection method is univariate filtering. These
approaches rank features according to some score, and the user selects the best k
features accordingly. Here the F-statistic (Anova), a generalization of the t-test, is
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used as a filter, as suggested in [55] and [39]. There are no parameters for this feature
selection method.
Wrapper approaches typically use some type of greedy strategy to select influential features using a black box classifier. They are more computationally intensive,
however SVM recursive feature elimination (SVM-RFE) is extensively used in medical applications [38]. The parameters considered were the penalty parameter and loss
function.
The final class of feature selection algorithms is embedded approaches where the
features are chosen while building the classifier. To represent this class two treebased methods were adapted; random forest (RF) [87] and extra-trees (ET) [49]. The
parameter considered was the number of trees used in each approach.
A summary of parameters of all considered feature selection methods along with
the range of values searched for each parameter are given in Table 2.8.

Classification methods
An exhaustive comparison of all classification algorithms would be quite challenging.
Therefore only a small number of approaches was explored, chosen to represent most
common machine learning approaches used in bioinformatics. Identifying the cancer
type from the NCI-60 dataset is inherently a multi-category classification problem.
Therefore each considered approach must accommodate this setting or be adaptable
by one-vs-one [51] or equivalent approaches. The types of algorithms tested fall into
three main categories: linear, tree, and distance based methods. Again we used the
Scikit-learn [81] Python implementations for all compared classification algorithms.
Linear classifiers use a linear function to score classes by taking the dot product
of feature values and feature weights computed during training. One of the most
powerful, flexible and ubiquitous linear classifier is the support vector machine (SVM)
with linear kernel [3]. SVM has been utilized in numerous works describing predictive
models with biological and medical significance. Both the penalty and loss function
parameters were explored. Another powerful linear classifier is logistic regression
(LR) [60]. The specific implementation uses one-vs-all to accommodate the multi32

classification setting instead of the one-vs-one approach. The penalty function, and
regularization parameters were explored.
Classification trees are a machine learning tool which has found extensive use in
the biological and medical communities. This is partially due to both their resilience
to over-fitting and ease of interpretation. This work looks at three related approaches;
vanilla decision trees (DT) [5], random forest (RF) [49] and gradient boosting (GB)
[106]. Decision trees represent class labels as leaves in the tree and branches are
combinations of features that lead towards a leaf. Vanilla decision trees can often
over-complicate the explanation necessary to arrive at the appropriate class label,
however their interpretation is very simple. Random forest approach and gradient
boosting are ensemble learning techniques where multiple trees are created and the
final decision is some aggregate. These approaches are less-susceptible to over-fitting
however they are often computationally intensive. The common parameter explored
is the number of trees used and for gradient boosting the number of boosting stages.
Distance based methods surveyed are k-nearest neighbors (KNN), cosine (Cos)
and correlation (Corr). Cosine and correlation are simple classifiers which calculates
the distance to all training samples from the test sample and assigns the label based
on the closest match. KNN is a slightly more advanced version of the same concept
however only 𝑘 neighbors are considered.
A summary of parameters of all considered classification algorithms along with
the range of values searched for each parameter are given in Table 2.9.

Validation strategy
A common validation strategy used in evaluating machine-learning is 𝑘-fold crossvalidation [39, 55]. Here the data is partitioned into 𝑘 equal size subsets with each
set used in turn for testing while the other 𝑘−1 subsets are used as training data. Care
must be taken taken to avoid substantial biases [105] by ensuring feature selection is
performed only on the data reserved for training. Since the approach presented here
is also parameterizing for each distinct model, nested 𝑘-fold cross-validation is used
to tune parameter values. This requires an additional cross-validation experiment
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on each training dataset, where a grid-search over the considered parameter range is
performed. The inner phase identifies the best parameter values which are then used
exclusively in the outer cross-validation. In order to build stronger evidence for the
models performance, the outer cross-validation phase was repeated 100 times, however the parametrization was only performed in the first iteration. Biases towards
selecting more complex models with more parameters or overly fine grid-steps are
still a possibility, however nested cross-validation should largely mitigate them. More
advanced techniques presented in [18] could be utilized in future iterations. Classification methods and embedded An outline of the validation strategy can be seen in
Figure 2-1

The nested 𝑘-fold cross-validation strategy is computationally very intensive. With
4×9 = 36 models (combinations of feature selection and classifier) to evaluate, dozens
of parameter values and different number of selected markers there can be upwards
of 1,000,000 individual classifier runs per data type. The majority of the jobs occur
in the inner cross-validation loop, and fortunately can all be run in parallel on a cluster or multi-core server. Also, a pre-filtering heuristic was applied to speed up the
feature selection process. For all datasets with more than 1,000 features we retained
only the top 1,000 features as ranked by the F-statistic prior to any additional feature
selection.

To further validate the results on external datasets, eight primary tumor cohorts
from The Cancer Genome Atlas (TCGA) were identified to match five NCI-60 tissueof-origin cell lines; central nervous system, colon, non-small cell lung, ovarian, and
renal. The mapping of the TCGA cohorts to the NCI-60 cell lines can be found
in Table 2.10. The TCGA derived gene expression micro-array data was obtained
from the Broad Institute’s GDAC Firehose utility [7, 14, 9, 10, 11, 12, 6, 8, 13].
The presented pipeline was used to selection biomarkers, identify and train the most
informative model using NCI-60 data [64]. Then its performance was tested using
the TCGA derived data.
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Metrics
There are numerous metrics used in evaluating the accuracy of a predictive model.
One common metric is AUC, or area under the receiver operating characteristic (ROC)
curve. The ROC curve is a plot of the true positive rate against the false positive
rate. The AUC is then the area under this curve and is used as a single measurement
of classifier performance. This definition is typically for binary classification tasks,
however there are several extensions to multiclass classification problems [24]. Since
the classes are equally represented in the NCI-60 dataset this work utilizes the multi∑︀
class metric, 𝐴𝑈 𝐶𝑡𝑜𝑡𝑎𝑙 = 𝑐𝑖 ∈𝐶 𝐴𝑈 𝐶(𝑐𝑖 ) · 𝑝(𝑐𝑖 ), where 𝐴𝑈 𝐶(𝑐𝑖 ) is the typical binary
classification AUC for class 𝑐𝑖 and 𝑝(𝑐𝑖 ) is the prevalence in the data of class 𝑐𝑖 .

ILP feature selection without replicates
The following ILP is a solution to the feature selection problem in absence of replicates. First an indicator variable 𝑥𝑗 ∈ {0, 1} is defined for all features. When set to 1
this variable indicates that its corresponding feature will be included in the solution
set. Another indicator variable 𝑦𝑖1 ,𝑖2 ∈ {0, 1} is defined for each 1 ≤ 𝑖1 ≤ 𝑖2 ≤ 𝑛.
This indicates if a particular pair of classes is covered by a given feature.
The ILP is defined as follows:
∑︀𝑝

min
s.t.

𝑗=1

∑︀𝑝

𝑗=1

∑︀

𝑥𝑗

𝑥𝑗 𝐷𝑗 (𝑖1 , 𝑖2 ) ≥ 𝑦𝑖1 ,𝑖2 ∀𝑖1 , 𝑖2 = 1, ..., 𝑛, 𝑖1 < 𝑖2

1≤𝑖1 <𝑖2 ≤𝑛

𝑦𝑖1 ,𝑖2 = 𝑟

The objective is to simply minimize the number of selected features. The first constraint ensures that when a feature is selected the pairwise coverage indicator variable is also selected. The second constraint ensures all classes are covered with some
amount of redundancy when possible. It may occur that two classes are not distinguishable. The value of 𝑟 can be calculated using a brute force search of all class
pairs and all variables or by solving the maximum distinct points problem.
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This ILP will be continually re-run until the number of chosen features equals 𝜃 as
described in algorithm 1. After each iteration the chosen features are removed from
𝐷. It should be noted that given there are 𝑛 cell types, then atleast 𝑙𝑜𝑔𝑛 number
of features are necessary to discriminate between all pairs. However typically 𝑛 is
small, and the number of available features is large enough that it is necessary to
come up with a strategy to distribute the discriminating power. The above strategy
will not only choose the minimum number of features but every class will have equal
discriminating power.

After features are selected it is necessary to then create a predictive model to make
classifications of unknown samples. This work utilizes the minimum distance classifier
which assigns an unknown sample the label of the closest known sample according to
some distance metric.
Algorithm 1 ILP Feature Selection
given 𝐷, distance matrix derived from 𝐸
𝑓 𝑒𝑎𝑡𝑢𝑟𝑒𝑠 = {𝑒𝑚𝑝𝑡𝑦}
while |𝑓 𝑒𝑎𝑡𝑢𝑟𝑒𝑠| =
̸ 𝜃 do
𝑟 = 𝑐𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑟 (𝐷)
𝑓 𝑒𝑎𝑡𝑠 = 𝐼𝐿𝑃 (𝐷)
𝑓 𝑒𝑎𝑡𝑢𝑟𝑒𝑠+ = 𝑓 𝑒𝑎𝑡𝑠
𝐷 = 𝐷 − 𝑓 𝑒𝑎𝑡𝑠
end while

2.3

Results and Discussion

This study is evaluating the effect of three parameters simultaneously: the model, the
data type and the number of markers. Therefore conclusions about the best predictive
model are presented from the perspective of each parameter individually. In Figure
2-2 an overview of the AUC for each model, in each data type at each number of
markers is presented as a heatmap. The hotter entries represent higher AUC.
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Model effects
The accuracy of the predictive models varies greatly, with the various combinations
of feature selection and classification algorithms. If the feature selection and classification algorithms are grouped by class, a high-level ranking becomes much clearer. In
Figure 2-3 the relative ranking of each model is indicated by color for each data type
at each number of features. The RFE-Linear combination which uses SVM-RFE for
feature selection and logistic regression or SVM for classification is the best performing model in almost all instances. Close behind is Ensembl-Linear, where in Table
2.4 it is clear that it performs only slightly worse than RFE-Linear.
If the data type and number of features are fixed the effects of the models can
be explored further. As seen in Figure 2-4 the mRNA and protein data types consistently afford the best classification accuracy at both high and low number of markers.
Although classifiers have relatively poor performance on SNP data for 8 markers, as
the number of selected biomarkers increases best performing classifiers based on SNP
data match or slightly outperform those based on gene and protein expression. The
accuracy of all models is generally highest at a high number of markers. Therefore
mRNA and SNP at 16 (Figure 2-5) and 64 (Figure 2-6) markers were chosen to
demonstrate model effects. Surprisingly, the effect of classifier choice is small as seen
in Figure 2-3. The models are grouped by feature selection algorithm. For RFE there
is very little difference between all the classifiers except decision trees and gradient
boosting which are consistently poor performers. The major differences appear between feature selection groups, where SVM-RFE is the best, random forest and extra
trees have equivalent performance, and Anova is the worst.
This conclusion is contrary to that of [39], where it was found that the t-test
univariate filter (of which Anova is considered a multiclass generalization) often performed the best for feature selection. This could be due to the differences in the underlying complexity of the question; namely in [39] the goal was to predict metastatic
relapse, which is a binary question, using gene expression micro-arrays. In addition,
no parameter tuning using nested CV or similar approach was performed in [39].
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Although this study cannot prove that a particular feature selection or classification
algorithm is best in a certain scenario, it does indicate that a thorough model selection
step is advised.
The relatively small effect of classifier choice is interesting and unexpected. This
indicates that much more care should be given to choosing the right features, as this
has the biggest effect on model performance.

Data type effects
The rich selection of data types available for these cell lines provides the opportunity
to compare the ability of many types of biological data to classify the tissue of origin
of a tumor cell line. Some of these data types fundamentally reflect gene expression
levels: mRNA, protein and microRNA. While the other two: CNV and SNP, are
generally assumed to reflect genomic changes at large (CNV) and small (SNP) scales.
Comparisons of data type effects at all marker sizes are best seen in Figure 2-4.
The transition from normal tissue to cancerous tissue is generally associated with
changes at the level of both gene expression and the genome. Frequent mutations,
genomic rearrangements and large scale changes in gene expression are all characteristic of oncogenic transformation. However, cancer cells also retain many, if not most,
of the essential hallmarks of the tissue of origin of the cancer. In this study, we use
the tissue of origin as the ground truth and measure the ability of each data type to
correctly infer the tissue of origin of a sample based upon each data type.
A priori, we expect some of these data types to be better at this task than others.
For instance, mRNA profiles are highly distinct between different tissue types. For
this reason, even after oncogenic transformation, an mRNA transcriptional profile
characteristic of the tissue of origin is expected to resemble that of the normal tissue,
more than it would the transcriptional profile of tumors derived from other tissues.
For this reason, we expect (and find) that mRNA transcriptional profiles reliably and
accurately infer the tissue of origin of tumor cell lines. Similarly, protein expression
profiles are also very reliable indicators of the tissue of origin of a tumor. microRNA
profiles are less powerful than either mRNA or protein expression profiles, but still
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fairly powerful indicators of tissue of origin. The relative weakness of microRNA
profiles compared to mRNA and protein expression profiles may in part result from
lower tissue specificity of microRNA expression relative to mRNA and protein.
The ability of genomic data to infer the tissue of origin of the tumor is subject to
a very different set of biological constraints than expression data. While expression
data is expected to be approximately identical across tissues regardless of patient
identity, and thus similar between tumors derived from the same tissue but from
different individuals; genomic data is identical across normal tissues in an individual, and differs between individuals. Thus, at first glance, genomic data would be
expected to track with the individual, and be a very poor predictor of the tissue of
origin of a cancer. However, dramatic genomic alterations are a hallmark of cancer
progression, and distinct genomic alterations are often found in distinct cancer types.
Accordingly, we find that copy number variation is about as powerful as microRNA
profiles at inferring the tissue of origin of a cancer cell. This is likely due to the
preferential occurrence of specific DNA rearrangements in cancers derived from specific cell types [88]. The SNP arrays however, which measure the presence of specific
alleles in a sample, show unexpectedly strong ability to infer the tissue of origin of
these cancer cell lines. Indeed, their performance is similar to that of the mRNA and
protein expression profiles (perhaps even better at high numbers of markers). This
was unexpected as SNPs should be roughly identical across all tissues in an individual, and by and large, reflect an individual’s ancestry. However, this phenomenon has
been previously observed in the NCI-60 data, and was found to result from the fact
that intensity of signal on the SNP array was actually reflecting SNP copy number
at duplicated loci, and thus indirectly measuring likely gene expression levels, rather
than homogenization of genotypic diversity [28]. This effect was strongest for linked
SNPs, and appears to be the result of local gene copy number amplification, which in
turn enables increased gene expression. Thus, the ability of SNP arrays to accurately
infer tissue of origin of cancer cell lines appears to result from increased gene expression driven by local duplication and increase in copy number. As the CGH arrays
used to profile the NCI-60 lines provide much lower genomic resolution than the SNP
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arrays, they are less powerful at detecting and exploiting this effect. This unexpected
behavior of the SNP arrays used to characterize the NCI-60 lines could be addressed
by utilizing newer SNP arrays that control for copy number such as the Affymetrix
SNP6 platform.

Number of marker effects
As one uses more biomarkers to classify samples, one expects increased performance,
the possibility of over fitting, and the appearance of a plateau beyond which additional
markers do not increase the power of classification. However, the rate at which these
changes occur as more markers are used to classify a sample can be very different for
various types of data.
Our analysis shows that mRNA, protein, and SNP data all plateau at about the
same AUC (∼0.97). However, each of these data types reaches the plateau at a
different number of markers: mRNA plateaus between 16 and 32 markers, while protein plateaus at around 32 markers, and SNP does not reach the same AUC until
64 markers are used. This may be result from the fact that each of these markers
appear to measuring aspects of gene expression, with decreasing directness (SNP) or
coverage (protein), and thus power of discrimination. The mRNA arrays used to characterize the NCI-60 cell lines provide direct assessment of the activity of thousands
of protein-coding genes, while the protein arrays measure only somewhat more than
300 proteins. With thousands of potential markers to choose from, the mRNA-based
models can select informative markers from a larger marker pool, and thus maximize
the performance of a gene expression-based model more quickly than the protein arrays, which are restricted to a small subset of the protein coding genes represented on
the mRNA arrays. The more direct nature of the protein measurement (i.e. closer to
the active biological component) does not appear to outweigh the disadvantage of the
lower coverage in the starting set of protein markers. As discussed in the preceding
section, the SNP array appears to be measuring, in part, gene expression levels resulting from the amplification of specific regions of the genome in specific cancer types.
However, there is likely to be a complex and possibly heterogeneous and non-linear
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relationship between signal intensity on the SNP array, and gene expression levels.
Thus, despite the very large number of markers to choose from on the SNP array,
highly informative markers are not as abundant in this data as they appear to be in
the mRNA data. As a result, many more SNP markers are required to achieve the
same level of performance as mRNA-based markers. It is hard to predict how the
power of SNPs to infer cancer type might change when newer arrays, that control for
copy number changes, are used to characterize these cell lines.
Similarly, CNV and microRNA markers approach the same level of performance
as one another, but do so at different rates. While microRNA markers plateau quickly
(at about 16 markers) CNV markers require 64-96 markers to reach the same level
of performance. The quick plateau of microRNA-based markers is likely due to the
highly tissue-specific expression of a minority of microRNAs, and the more global
expression of the remaining majority. Once the few highly informative microRNAs
have been selected and used, adding more provides little additional classification
power. In the case of CNVs, like SNPs these markers reflect changes in the cancer
cells genome that can lead to changes in gene expression that are distinctive features
of cancer subtypes. However, not only do the CNV markers suffer from the indirect
relationship between the marker and gene expression expected for SNPs, they are
also a much lower resolution marker than SNPs (megabases vs single bases), and
far fewer CNVs were measured on the arrays, thus limiting the likelihood that the
most informative CNVâĂŹs were available for selection. Thus, the power of the CNV
biomarker panel climbs slowly.
Taken together, these observations suggest that the absolute performance of a
given biomarker data type to classify a cancer can be understood in the context of:
the number of available markers for the model to choose from, the power of the most
informative markers in the set, and the directness with which the data type reflects
an informative aspect of the sample biology. Data types with a large number of
markers to choose from, that are closely related to the biology of the sample, are
most likely to yield highly effective small biomarker panels. While data types with
lower saturation (fewer markers measured), and/or a less direct relationship to the
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biological differences between samples, will require more markers to reach maximal
performance.

Combined model, data type, and number of marker effects
Ultimately all parameters should be considered simultaneously when attempting to
build the best targeted predictive model. In order to do this it is necessary to build
a validation framework to explores all parameters fairly and efficiently. Although it
is a difficult task it is not impractical and interesting nuances can be extracted.
In this study it was observed that at the lowest number of markers (8) mRNA
and protein were the best data types for cancer identification. For mRNA, SNP and
protein the SVM-RFE was the best feature selection choice and ET was the best
classifier. For CNV and microRNA the best classifier was LR and ET respectively.
Interestingly for all data types at 8 markers except CNV a tree based classifier performed the best as seen in Table 2.4. It is possible that if only a few biomarkers
are considered the tree based approaches explicit enumeration of decisions may be
better suited, however it should be noted that the linear classifiers are typically only
marginally worse.
At the highest number of markers tests (96) both RFE and ET perform strongly
on all data types, however LR is the best classifier for all types expect SNP where
KNN is the best. Both of these classification tools are technically simple, yet they
perform this best which lends credence to the Occam’s razor principle which when
applied to machine learning places preference on simpler explanations.

External validation
The amount of over-fitting when building a predictive model is always a concern.
This effect was measured in an external validation experiment utilizing analogous
gene expression micro-array data obtained from several studies which are part of the
TCGA project [7, 14, 9, 10, 11, 12, 6, 8, 13]. The results of this comparison indicated
that biomarker and model selection using AUC as the ranking criteria is robust and
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performs well across studies. In Table 2.5 it can be seen that colon (CO), CNS and
renal (RE) cancer types were distinguishable with a high degree of accuracy using
between 8 and 96 markers. The CNS type was more challenging to differentiate after
32 markers, while ovarian (OV) and lung cancers (LC) were extremely difficult to
differentiate at any marker size.
The NCI-60 data is derived from decades old cell lines, while the TCGA was
derived from recently sampled from primary solid tumor. Additionally the matched
cancer types did not have comparable histological classification. Finally there three
additional cancer types (ME, LE, BR) which were present in NCI-60 but not included
in the external validation set. These classes were included in the training. Despite
these differences the presented method was able to perform biomarker selection and
build accurate predictive models for this challenging external validation experiment.
A complete breakdown of the per-class prediction rate by cancer marker set size is
provided in Table 2.11.

No replicates
Typically some type of k-fold cross-validation is used to evaluate the performance of a
predictive model. However in this scenario leave-out-out cross-validation (LOO CV)
on the 𝑛 cell types is utilized. Assume that a lineage of the 𝑛 cell types is available.
At each iteration, a cell type is left out as the test cell type and the other 𝑛1 cell
types are used to select a panel of q markers. This test cell type is then searched
against the 𝑛1 cell types using the chosen marker panel.

Since a single cell type is left out, it cannot be matched against itself. The best
case scenario is to map it to an adjacent cell type in the lineage. Hence, the score of
a candidate is found by 2𝑑1 , where 𝑑 is the distance between the candidate and the
true cell type in the given lineage. This way, a candidate cell type gets a score of 1
if it is adjacent to the true cell type. After 𝑛 iterations, AUC can be calculated. To
determine the size of a marker panel, a search of the number markers 𝑞 in a range,
e.g. {6, 7, , 96}.
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SVM
Cosine
Correlation
Hamming

RFE/digi
97.84
95.76
96.97
49.95

RFE/expr
97.91
95.37
96.84
49.95

Greedy
97.78
94.29
96.42
49.95

ILP
97.87
93.83
96.23
49.95

Table 2.3: AUC of evaluated methods
SCLD Data
In this experiment, we considered only markers in our curated data set of 28 cell types.
Among these markers, 361 of them were found in the reference database. Therefore,
the reference database can be viewed as a 28 x 361 expression matrix. Results can
be seen in table 2.3.

2.4

Conclusion

The initial hypothesis motivating this research was that certain predictive models
will perform better on different data types at different dimensionality. While this
hypothesis holds, the difference in accuracy between models is often small and allows
for several generalizations. Namely that RFE is clearly the best feature selection
algorithm and both SVM and LR are the best classifiers as seen in Figures 2-2 and
2-3. Both mRNA and protein expression are the overall best performing data types
for the cancer classification question. However to maximize predictive accuracy all
models at all parameters should be parameterized and vetted fairly before conclusions
are made.
The performance of the ILP on no-replicate data as seen in Table 2.3 indicates that
it performs no worse, but no better than the recursive feature elimination approach
given the right paired classifier. Interestingly there was little difference between the
ILP and the greedy approach. However the flexibility of the ILP enables it to be
easily adapted to other scenarios, such as the introduction of covariances, or class
specific weights.
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Table 2.4: Table of AUC for top performing models for each data type and grouped
by marker set size.
#

8

SNP

RFE ET

mRNA

CNV

microRNA

0.8598 RFE ET

0.9585 RFE LR 0.7198 RFE

RF

Protein

0.8352 RFE ET

0.9426

RFE

RF

0.8591

RFE

RF

0.9554

ET

LR 0.7115

RFE

SVM

0.8352

ET

ET

0.9394

RFE

SVM

0.8321

RFE

SVM 0.9521

RF

LR 0.71

RFE

KNN

0.8295

RFE

RF

0.9382

ET

ET

0.8295

RFE

LR

RFE

ET 0.691

RFE

ET

0.8275

RF

ET

0.9376

RFE

KNN 0.9467

RFE

RF 0.6802

Anova SVM

0.8089

ET

RF

0.9312

Anova LR

0.8051

RF

RF

0.9272

RF

0.8028

16 RFE ET

0.951

0.922

RFE ET

0.972

ET

ET

RF

RF

0.8027

RFE

LR

0.8021

RF

LR

0.802

LR 0.7616 RFE

SVM 0.8758 RFE ET

0.9666

RFE

RF

0.9162

RFE

LR

0.9709

RFE

LR 0.7607

RFE

KNN

0.8704

ET

ET

0.9582

RFE

SVM

0.9111

RFE

RF

0.9681

RF

LR 0.7468

RFE

RF

0.8671

RFE

RF

0.9565

RFE

KNN

0.9033

RFE

SVM 0.968

RFE

ET

0.8597

ET

ET

0.8997

RFE

Cos

RFE

LR

0.8535

RFE

LR

0.897

RF

ET

0.896

ET

RF

0.8914

32 RFE LR

0.9663

Anova SVM

0.8496

0.9685 RFE LR

0.9759 RFE LR 0.8194 RFE

KNN 0.8806 RFE ET

RFE

SVM

0.9674

RFE

ET

0.9757

RFE

RF

0.8801

RFE

KNN

0.966

RF

LR

0.9747

RFE

ET

0.8717

RFE

ET

0.9646

RFE

Cos

0.9736

RFE

SVM

0.8679

RFE

RF

0.9577

RFE

RF

0.9734

RFE

LR

0.866

RFE

SVM 0.9734

64 RFE KNN 0.9911 RF

0.9792

LR

0.9789 RFE LR 0.8379 RFE

KNN 0.8746 RFE ET

0.979

RFE

LR

0.9892

RFE

LR

0.9777

RFE

LR

0.8688

RFE

LR

0.9782

RF

LR

0.9862

RFE

Cos

0.977

RFE

RF

0.8682

RF

LR

0.9731

RFE

SVM

0.9843

RFE

ET

0.976

RF

LR

0.8595

RFE

KNN 0.9727

ET

LR

0.9837

RFE

RF

0.9757

RF

Corr

0.8585

RF

RF

0.9755

RFE

ET

0.8578

ET

LR

0.9741

RF

KNN

0.8574

RF

ET

0.9737

RFE

SVM

0.8568

RFE

SVM 0.9733

Anova KNN

0.8564

ET

RF

0.9728

Anova LR

0.8557

RFE

Corr

0.9709

ET

LR

0.8539

RFE

Corr

0.8537

ET

Corr

0.8536

Continued on next page
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– Continued from previous page
#

SNP

mRNA

96 RFE KNN 0.9933 RF
RF

LR

0.9918

RFE

CNV

microRNA

Protein

ET

KNN

0.852

RFE

Cos

0.8492

LR

0.9808 RFE LR 0.847

RFE

LR

0.8697 RF

LR

0.979

LR

0.9787

RF

KNN

0.8657

RFE

LR

0.9779

ET

LR 0.8292

RFE

LR

0.9916

RF

RF

0.9774

RF

LR

0.8643

ET

LR

0.9768

ET

LR

0.9909

RFE

Cos

0.977

ET

LR

0.8634

RFE

ET

0.9765

RFE

RF

0.9762

RFE

RF

0.8633

ET

ET

0.9734

ET

LR

0.9761

RF

Corr

0.863

RF

ET

0.973

ET

RF

0.9758

ET

Corr

0.8629

RF

ET

0.9746

RFE

KNN

0.8628

RFE

ET

0.9744

ET

KNN

0.8613

Anova KNN

0.8596

Anova LR

0.8573

RFE

SVM

0.853

ET

RF

0.8483

RFE

Corr

0.8477

RF

SVM

0.8474

Table 2.5: Accuracy of the top performing model for each cancer type and grouped
by marker set size.
Marker Set Size
8
16
32
64
96

CO
0.1673
0.9856
1
1
1

OV
0
0.037
0.1111
0.0741
0.2593

CNS
1
0.8246
0.9123
0.5965
0.5351

LC
0.3656
0.686
0.2384
0.1163
0.0116

RE
0.0138
0.7403
0.8571
0.8961
1

Table 2.6: Data files and normalization strategy used for each data set.
Data Type CellMiner Data Type

Norm.

CellMiner File Name

SNP

DNA: Affy 500K SNP

CRLMM

nci60_DNA__Affy_500K_SNP_CRLMM.txt.zip

mRNA

RNA: Affy HuEx 1.0

GCRMA

nci60_RNA__Affy_HuEx_1.0_GCRMA.txt.zip

CNV

DNA: aCGH Agilent 44K

AgelentFE nci60_DNA__aCGH_Agilent_44K_AgilentFE.txt.zip

microRNA

RNA: microRNA OSU V3 chip log2

Protein

Protein: Lysate Array

nci60_RNA__microRNA_OSU_V3_chip_log2.txt.zip

log2

nci60_Protein__Lysate_Array_log2.txt.zip
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Inner Cross Validation

Outer Cross Validation

Feature
Selection
Algorithms

Classi cation
Algorithms

Parameterization
Feature Selection



Classi cation

Repeat k times

Rank by AUC

Repeat k times
Feature Selection

Classi cation

Rank by AUC

Figure 2-1: Flow chart of the validation strategy. First all combinations of feature
selection and classification algorithms (4x9) are parameterized in the inner k-fold
cross-validation loop based on the training folds of the outer k-fold cross-validation.
The best parameters are found by maximizing AUC. Once the parameters are fix the
outer k-fold cross-validation loop is run and the average AUC (or similar metric) is
recorded.
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Models Grouped by Feature Selection

Comparing Models within Marker Set Size
0.95
0.90
0.85
0.80

Mean AUC

RFE-SVM
RFE-LR
RFE-KNN
RFE-GB
RFE-DT
RFE-Cos
RFE-Corr
RFE-RF
RFE-ET
RF-SVM
RF-LR
RF-KNN
RF-GB
RF-DT
RF-Cos
RF-Corr
RF-RF
RF-ET
ET-SVM
ET-LR
ET-KNN
ET-GB
ET-DT
ET-Cos
ET-Corr
ET-RF
ET-ET
Anova-SVM
Anova-LR
Anova-KNN
Anova-GB
Anova-DT
Anova-Cos
Anova-Corr
Anova-RF
Anova-ET

0.75
0.70
0.65
0.60
0.55
8 16 32 64 96 8 16 32 64 96 8 16 32 64 96 8 16 32 64 96 8 16 32 64 96
mRNA
Protein
microRNA
SNP
CNV

Marker Set Size Grouped by Platform

Figure 2-2: This heatmap contains the average AUC for each model (grouped by
feature selection) for each data type at each number of markers. The darker the
block, the more accurate the predictive model is.
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Comparing Models within Marker Set Size

9

Ensembl-Tree

8
7

Ensembl-Distance
RFE-Tree

6

RFE-Linear

5

RFE-Distance

4

Model Rank

Models Grouped by Feature Selection

Ensembl-Linear

Anova-Tree

3

Anova-Linear

2

Anova-Distance
8 16 32 64 96 8 16 32 64 96 8 16 32 64 96 8 16 32 64 96 8 16 32 64 96
mRNA
Protein
microRNA
SNP
CNV

1

Marker Set Size Grouped by Platform

Figure 2-3: This heatmap contains the relative rank based on AUC of each model
across all data types. The darker spots indicate higher AUC and rank.
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One-sided 95% Confidence Interval of Top Model within Platform and Marker Set Size
1.0

0.95

0.9

AUC

0.85

0.8
mRNA
Protein
microRNA
SNP
CNV

0.75

0.7

CNV

SNP

Protein

mRNA

CNV

microRNA

Platforms Grouped by Marker Set Size

96
SNP

microRNA

Protein

mRNA

CNV

64
SNP

microRNA

mRNA

Protein

CNV

32
SNP

microRNA

mRNA

Protein

SNP

16
CNV

microRNA

mRNA

8
Protein

0.65

Figure 2-4: This figure contains box plots of the best model, for each data type and
number of markers. The whiskers represent the 95% confidence interval, while the
green dots represent another model with performance within the confidence interval.
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Pl a t f o r m SN P - D i s t r i b u t i o n o f AUC a t 1 6 M a r k e r s p e r M o d e l
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NN
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-RF
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Anova-RF

0.5

Anova-ET
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1.0

0.95

0.9

0.85

AUC

0.8

0.75

0.7

0.65

0.6

0.55

0.5

M o d e l s Gr o u p e d b y Fe a t u r e Se l e c t i o n

Figure 2-5: This figure contains box plots describing the AUC of each model, grouped
by the feature selection component for SNP and mRNA data type at 16 markers.
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Pl a t f o r m SN P - D i st r i b u t i o n o f AUC a t 6 4 M a r k e r s p e r M o d e l
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Figure 2-6: This figure contains box plots describing the AUC of each model, grouped
by the feature selection component for SNP and mRNA data type at 64 markers.
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mRNA

CNS
Cell Lung

Breast

Type

Data

Table 2.7: Cell Lines used in Analysis

RE.SN12C

RE.RXF_393

RE.CAKI_1

RE.ACHN

RE.A498

RE.786_0

Renal

RE.SN12C

RE.RXF_393

RE.CAKI_1

RE.ACHN

RE.A498

RE.786_0

RE.UO_31

OV.NCI_ADR_RES RE.TK_10

OV.SK_OV_3

OV.OVCAR_8

OV.OVCAR_5

OV.OVCAR_4

OV.OVCAR_3

OV.IGROV1

RE.UO_31

OV.NCI_ADR_RES RE.TK_10

OV.SK_OV_3

OV.OVCAR_8

OV.OVCAR_5

OV.OVCAR_4

OV.OVCAR_3

OV.IGROV1

Ovarian
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Non-Small

LC.NCI_H460
LC.NCI_H522

CO.SW_620

ME.MDA_N

ME.SK_MEL_5

ME.SK_MEL_28

ME.SK_MEL_2
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LC.NCI_H226 LE.RPMI_8226
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BR.HS578T
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Melanoma
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OV.NCI_ADR_RES

OV.SK_OV_3

OV.OVCAR_8

OV.OVCAR_5

OV.OVCAR_4

OV.OVCAR_3

OV.IGROV1

Ovarian

RE.UO_31

RE.TK_10

RE.SN12C

RE.ACHN

RE.A498

RE.786_0

Renal

Table 2.8: The tested parameters for each feature selection algorithm.
FS Method

Parameter

Description

Values

Anova

NA

No parameters

RFE

Estimator

The supervised learning esti- Support Vector Classification
mator

(SVC) with a linear kernal for
the decision functions

Estimator Parameter - C The penalty parameter of the 0.25, 1, 4, 16, 64, 256
error term

Random Forest Max Features

Function

to

determine

the sqrt and log2

number of features to consider
when looking for best split
N Estimators

The number of trees to be used 10, 50, 100, 250
in the forest

Extra Trees

Max Features

Function

to

determine

the sqrt and log2

number of features to consider
when looking for best split
N Estimators

The number of trees to be used 10, 50, 100, 250
in the forest
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Table 2.9: Classification Parameters
CL Method

Support

Vector

Parameter

Ma- Kernel

chine

Description

Values

Function to use as a decision RBF and Linear
function

RBF Gamma

Kernel coefficient for RBF

0.03125, 0.125, 0.5, 2, 8, 32,
128, and 512

RBF C

Penalty Parameter of the error 0.03125, 0.125, 0.5, 2, 8, 32,
term

Linear C

128, and 512

Penalty Parameter of the error 0.03125, 0.125, 0.5, 2, 8, 32,
term

Logistic Regression

Penalty
C

128, and 512

Norm used in the penalization l2
Inverse

of

strength;

regularization 0.25, 1, 4, 16, 64, and 256
smaller

values

specify stronger regularization

Decision Trees

Max Features

Function

to

determine

the sqrt and log2

number of features to consider
when looking for best split

Random Forest

Max Features

Function

to

determine

the sqrt and log2

number of features to consider
when looking for best split
N Estimators

Number of trees to be used in 10, 50, 100, 250
the forest

Extra Trees

Max Features

Function

to

determine

the sqrt and log2

number of features to consider
when looking for best split
N Estimators

Number of trees to be used in 10, 50, 100, 250
the forest

Gradient Boosting

N

Boosting Number of boosting stages to 100, 250, and 500

Stages

perform

Max Depth

Maximum depth of the individ- 3, 5, 7
ual regression estimators

K-nearest Neighbors

Compute Near- Algorithm used to compute the BallTree and KDtree
est Neighbor

nearest neighbors

Distance Func- Function used to calculate the Euclidean and Manhattan
tion

distance

Continued on next page
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CL Method

Parameter

Weight

Description

Values

Func- A function to apply weights to Uniform and Inverse weighting

tion

the points

based on the distance to their
neighbors; the closer the distance the better the score.

Cosine

NA

No parameters

Correlation

NA

No parameters

Table 2.10: External Validation: NCI-60 to TCGA mapping
NCI-60 Cell Line
Central Nervous System
Lung
Colon
Ovarian
Renal

TCGA Cell lines
Glioblastoma multiforme (GBM)
Brain Lower Grade Glioma (LGG)
Lung adenocarcinoma (LUAD)
Lung squamous cell carcinoma (LUSC)
Colon adenocarcinoma (COAD)
Rectum adenocarcinoma (READ)
Serous Cystadenocarcinoma (OV)
Kidney renal clear cell carcinoma (KIRC)
Kidney renal papillary cell carcinoma (KIRP)

Table 2.11: Accuracy per Cancer Type Grouped by Marker Set Size.
TCGA

#

NCI-60 Cell Lines

Samples

Markers

ME

LE

CO

CNS

RE

BR

OV

LC

CNS

8

0.0

0.0

0.0

1.0

0.0

0.0

0.0

0.0

CO

8

0.0144

0.0048

0.1779

0.0769

0.0048

0.0192

0.4135

0.2885

LC

8

0.0291

0.0058

0.0058

0.3081

0.1977

0.0174

0.0

0.436

OV

8

0.4074

0.1852

0.0

0.0

0.0

0.0

0.0

0.4074

RE

8

0.0

0.0

0.0649

0.7013

0.0

0.0

0.1039

0.1299

CNS

16

0.0

0.0

0.0

0.8246

0.1754

0.0

0.0

0.0

CO

16

0.0

0.0

0.9856

0.0

0.0144

0.0

0.0

0.0

LC

16

0.0

0.0058

0.064

0.0523

0.1512

0.0407

0.0

0.686

OV

16

0.0

0.2222

0.037

0.0

0.0

0.0

0.037

0.7037

RE

16

0.013

0.026

0.0649

0.0519

0.7403

0.013

0.0649

0.026

Continued on next page
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TCGA

#

Samples

Markers

ME

LE

CO

NCI-60 Cell Lines
CNS

CNS

32

0.0

0.0877

0.0

CO

32

0.0

0.0

1.0

RE

BR

OV

LC

0.9123

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

LC

32

0.0

0.0581

0.2151

0.1279

0.2791

0.0814

0.0

0.2384

OV

32

0.0

0.7037

0.1481

0.0

0.0

0.037

0.1111

0.0

RE

32

0.0

0.0779

0.0

0.013

0.8571

0.0

0.039

0.013

CNS

64

0.0

0.386

0.0

0.5965

0.0175

0.0

0.0

0.0

CO

64

0.0

0.0

1.0

0.0

0.0

0.0

0.0

0.0

LC

64

0.0

0.0872

0.064

0.0058

0.7035

0.0233

0.0

0.1163

OV

64

0.0

0.4074

0.1481

0.0

0.1111

0.0741

0.0741

0.1852

RE

64

0.013

0.0909

0.0

0.0

0.8961

0.0

0.0

0.0

CNS

96

0.0

0.4386

0.0

0.5351

0.0263

0.0

0.0

0.0

CO

96

0.0

0.0

1.0

0.0

0.0

0.0

0.0

0.0

LC

96

0.0

0.1802

0.2209

0.0174

0.5233

0.0465

0.0

0.0116

OV

96

0.0

0.4074

0.2222

0.0741

0.037

0.0

0.2593

0.0

RE

96

0.0

0.0

0.0

0.0

1.0

0.0

0.0

0.0
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Chapter 3
Single-cell Assisted Deconvolution
Separation of component signals from biological data has been an open challenge
for a number of years. This problem is found in many other domains and is often
referred to as signal separation problem. Recent advances in single cell genomics have
enabled researchers to sample gene expression signatures of single cells and they are
now able to accurately measure the canonical gene expression profiles of given cell
types. Using this additional data type the following work will demonstrate how a
simple existing deconvolution approach can be enhanced to yield greater accuracy
than methods which do not take advantage of single cell data.

3.1

Motivation

Cell or tissue type heterogeneity is present in data collected from numerous biological
sources. It is typically too difficult or impossible to physically separate cell types
in any given mixture. Computational gene expression deconvolution is the process
by which this separation is done in silico [68]. One application of deconvolution is
assisting stem cell biologists in obtaining whole-transcriptome expression profiles of
closely related cell types. Here we present an approach that utilizes single-cell qPCR
probing of a small number of genes to aid in the deconvolution of whole-transcriptome
profiles of mixed samples.
The expression profiles of 𝑚 genes measured in 𝑛 mixtures of 𝑘 cell types are
61

modeled as 𝑋 = 𝑆𝐶, where 𝑋 is a 𝑚 × 𝑛 matrix whose columns are the expression
profiles of individual mixtures, 𝑆 is 𝑚 × 𝑘 signature matrix whose columns are expression profiles of individual cell types, and 𝐶 is a 𝑘 × 𝑛 concentration matrix whose
columns represent the proportions of each cell type in individual mixtures. There
are a variety of approaches used to solve the deconvolution problem and they can be
classified based on the expected input and output.
One formulation used by [102] propose the problem as estimating 𝑆 when the mixtures 𝑋 and concentrations 𝐶 are known. Typically the concentrations are measured
by some external technique such as FACS or FISH. Another formulation [33, 86, 2]
is to assume 𝑋 and 𝑆 are known, and the goal is to estimate 𝐶. This formulation
is often found when studying extensively studied cell types such as the blood lineage
and is often referred to as supervised deconvolution. Unsupervised deconvolution is
the simultaneous estimation of both 𝑆 and 𝐶 given 𝑋. This scenario is much more
challenging, however several approaches have yielded promising results [97, 58, 112].
Finally the semi-supervised formulation assumes that existing information such as
unique marker genes are available to describe each cell type [29].
This work proposes a novel variation on these previously proposed themes where
in addition to the bulk mixture data, single-cell expression profiles denoted as 𝑍 =
𝑧1 , 𝑧2 , ...𝑧𝑞 where 𝑞 is the number of single cells available. Typically this comes from
a microfluidic device that performs qPCR or RNA-Seq reactions on each single-cell.
This additional data can be pre-processed into the canonical cell type signatures
where typical supervised deconvolution approaches are applicable.
One common application of single cell genetics is the detection of rare cell types.
These rare cells can be progenitor stem cells which will only ever be present at an
extremely low abundance, or potentially the cell type is rare because it is a subtle
response to changes in environmental conditions. The likelihood that these rare cells
are sample in the single cell experiments is proportional to its frequency. This makes
experimentally measuring extremely rare cells quite difficult. This work will present
first steps towards computationally inferring the canonical signature of rare cell types
which cannot be directly measured.
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3.2

Problem Definition

The motivation of this work is to deconvolve population level (i.e. mixtures) given a
small number of single-cell resolution measurements from the same sample. We will
denote by 𝑚 the number of genes, by 𝑘 the number of cell types, and by 𝑛 the number
of samples.
The gene expression level measured by qPCR for a gene 𝑖 is typically given as
the threshold cycle 𝐶𝑇𝑖 . This measurement varies logarithmically with the abundance
level.
The 𝐶𝑇𝑖 values are often normalized using a constantly expressed housekeeping
gene (or the geometric average of several housekeeping genes) in order to account
for variances in starting material which would effect detection threshold. Thus the
normalized values are reported as
∆𝐶𝑇𝑖 = 𝐶𝑇𝑖 𝑡𝑎𝑟𝑔𝑒𝑡 − 𝐶𝑇𝑖 𝑟𝑒𝑓 𝑒𝑟𝑒𝑛𝑐𝑒𝑔𝑒𝑛𝑒
The ∆𝐶𝑇𝑖 values can be converted to a linear scale by using
𝑖

2−Δ𝐶𝑇
as expression level.
A mixture is a heterogeneous collection of cells where the expression levels of 𝑚
selected genes are measured using qPCR. A single measurement is denoted by the
vector 𝑥, where |𝑥| = 𝑚. A set of 𝑛 mixtures is denoted as the mixture matrix 𝑋
with dimensions 𝑚 × 𝑛.
The signature for a given cell type is denoted as a vector 𝑠, where |𝑠| = 𝑚, and
each element in the vector is the mean expression value of each gene in cells of this
type. The complete set of signatures for all cell types is denoted as 𝑆 where 𝑆 is an
𝑚 × 𝑘 matrix.
Each mixture is assumed to be a linear combination of cell-type signatures. For
one mixture the concentration of each cell type is denoted by a vector 𝑐, where
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|𝑐| = 𝑘. A set of 𝑛 concentration vectors is denoted as the concentration matrix 𝐶
with dimensions 𝑘 × 𝑛.
Thus, expression data of a set of mixtures is modeled as
𝑋 = 𝑆𝐶
where each heterogeneous mixture is a linear combination of cell type signatures with
concentrations specified by the columns of 𝐶.

3.3

Method

We use a two step approach whereby single cells are first clustered into representative
cell types and the signature matrix is computed. Next the mixing proportions matrix
𝐶 is estimated using quadratic programming.

3.3.1

Signature generation

One of the core challenges of single cell genetics is the meaningful classification or
grouping of cells. For the purposes of this work the term cell type will be broadly
defined as a cell phenotype that is statistically separable based on gene expression
data. The signature matrix 𝑆𝑚×𝑘 is built by clustering the single-cell qPCR data
𝑧1 , 𝑧2 , ...𝑧𝑞 into 𝑘 clusters. This problem is an instance of unsupervised learning,
where samples need to be labeled based on their gene expression vectors. Numerous
objectives have been proposed such as minimizing the distance between samples in a
cluster, and others focus on grouping functionally related samples. K-means clustering
was chosen to group the single-cell data because it explicitly allows us to control the
number of theoretical cell-types. The average expression profile of each single-cell in
a cluster is used to create the cell-type signature matrix 𝑆𝑚×𝑘 .
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3.3.2

Concentration matrix

The next task is to solve for the concentration matrix 𝐶𝑘×𝑛 . This is done utilizing
the same methodology described in [33]. Each column of 𝑋 corresponds to genes
measured by qPCR, and is a linear combination of single cell expression profiles
with unknown concentrations. Let us denote a particular column in 𝑋 as 𝑥 and
its corresponding column in 𝐶 by 𝑐. Inferring 𝑐 can be formulated as the following
quadratic program:
||𝑆𝑐 − 𝑥||2
∑︁
𝑐=1

minimize
subject to

𝑐𝑖 ≥ 0 ∀𝑖 = 0...𝑚
This least-squares formulation can be solved with any constrained quadratic programming solver.

3.3.3

Missing cell type

Solving for a missing cell type is an extension of the above computational deconvolution framework. The signature matrix including the missing cell type will be denoted
as 𝑆ˆ𝑚×(𝑘+1) , and the concentration matrix will be denoted 𝐶ˆ(𝑘+1)×𝑛 . The goal is to simultaneously calculate the missing 𝑘th column of signature matrix and the complete
concentration matrix. The quadratic formulation is the following:
||𝑆ˆ𝐶ˆ − 𝑋||2
∑︁
𝑐=1

minimize
subject to

𝑐𝑖 ≥ 0 ∀𝑖 = 0...𝑚
𝑠𝑘 ≥ 0
This is a non-linear non-negative least squares optimization problem. While problems of this nature can be quite challenging there is quite a large body of work dedicated towards efficiently solving these types of optimization problems. The technique
known as damped least-squares (DLS) [56, 71] is used here. The missing cell type sig65

nature is initialized as the average of all the known cell types and the concentrations
are set uniformly.
One additional challenge is determining if there is a missing cell type present in the
mixtures. This is addressed by comparing the residual value of the system with and
ˆ respectively 𝑟 = |𝑋 − 𝑆𝐶|. If 𝑟ˆ > 𝑟 + 𝛾
without the missing cell type, 𝑟ˆ = |𝑋 − 𝑆ˆ𝐶|,
where 𝛾 is some small constant then our approach will report that a missing cell
type is likely present. The small constant is in place in order to require a non-trivial
difference between the two scenarios.

3.3.4

Simulation

This work relies on two types of data, single cell and bulk data from the same source
measured with the same technology. The combination of these data types is not available in any public data sources. Therefore it is necessary to simulate such datasets.
The single cell data used as the basis for the simulations comes from a publication
which assessed different methods for measuring single cell gene expression [34]. Here
101 cells from 5 cell types (hematopoietic, intestinal, mammary gland, prostate and
neural stem cells) were obtained and measured using the Fluidigm C1 and Biomark
HD platforms. The 280 genes were chosen using a literature guided approach for
known stem cell and lineage specific marker genes. The qPCR data was processed
using Fluidigm software but no normalization to housekeeping genes was performed.
In order to properly asses the accuracy of the deconvolution and missing celltype prediction a semi-continuous model for simulating both single cell and mixture
data sets has been adopted. The main motivation behind this model is the bi-modal
nature of gene expression observed in single cell experiments [73, 98, 34]. This previously noted property finds that genes are both absent and highly expressed in similar
cells. The presented model therefore has two components; the probability of a gene
being expressed in a cell, along with the the expression value of that gene when it
is expressed. The presented model most closely mirrors the semi-continuous model
presented in [73].
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Active Transcription
Non-zero 𝐶𝑇𝑖 value measurements of a gene 𝑖 for a particular cell type 𝑙 are assumed
to follow a normal distribution, 𝑁 (𝜇, 𝜎 2 ). In our experiments the parameters of
this normal distribution have been estimated from the training single cell data. The
random variable is denoted as 𝑞𝑙𝑖 .
Expression Probability
The probability that a particular gene is expressed and detected can be estimated
directly by counting the number of non-zero expression values for a given gene 𝑖 and
cell type 𝑙. The random variable is denoted as 𝑝𝑖𝑙 .
Combined Model
These two components can be combined in a variety of ways to create a model for
simulating single-cell observations. For a given gene 𝑖 and cell type 𝑙:
1. 𝑊𝑙𝑖 = 𝑝𝑖𝑙 · 𝑞𝑙𝑖 . Under this model each gene has a certain probably of being expressed, and when it is, the expression level is taken from the normal distribution
fitted from the training data available for that gene and that cell type.
2. 𝑊𝑙𝑖 = 𝑞𝑙𝑖 . This is a special case of the previous model under which genes are
assumed to always be expressed.
1 + 𝑝𝑖𝑙 𝑖
· 𝑞𝑙 . In this scenario only the fraction of the expression probability
2
stemming from technical error is represented.

3. 𝑊𝑙𝑖 =

This bi-modal property can be observed by viewing the gene expression distribution of a random gene taken from the starting dataset. The true and simulated
distributions are seen side-by-side in figure 3-1.
The procedure for creating simulated single cell for cell type 𝑖 is:
1. for all 𝑗 = 1..𝑚 estimate 𝑝𝑖𝑗 .
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2. for all 𝑗 = 1..𝑚 estimate the parameters of the normal distribution and sample
to obtain 𝑞𝑗𝑖
3. for all 𝑗 = 1..𝑚 multiply 𝑝𝑖𝑗 by 𝑞𝑗𝑖
Two different scenarios were explored for simulating the concentration matrix 𝐶.
The first is simply a uniform concentration of all cells. This implies a concentration
1
of
for this study. The second type was sampling uniformly at random from 0
5
to 1 exclusive for every cell type, then normalizing by the sum. This ensures the
concentration of each cell type in a mixture sums to 1 and there are both high and
low concentration cell types.
The mixtures were created by repeatedly sampling single cells according to the
proportions dictated by 𝐶. The per gene expression levels were added together to
create a single mixture. In this simulation, no appropriate housekeeping gene was
available for normalization, so the gene expression levels for the mixtures were simply
divided by the total number of cells. Normalizing single cell qPCR data is still an
open concern [65, 74].
An error term is used in the simulations, 𝑒 = 5, 10, 25, 50, 100, 200 which becomes
which acts as the noise parameter and it represents the number of single-cell’s used
to create a particular mixture. The fewer single cells used, the more different that
mixture will be than the sum of cell type signatures.
Unless otherwise stated each experiment was run 10 times and the presented
results are the average of the 10 replicates.

3.4
3.4.1

Results and Discussion
Existing tools

There are several published tools [102, 33, 86, 2, 97, 58] for solving both the supervised
and unsupervised gene expression deconvolution problem. The formulation presented
here sits between these two versions of the problem. The completely supervised
approaches are not able to adequately deconvolve the systems studied here because
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Figure 3-1: A violin plot of the true and simulated gene expression distribution of the
KIT gene for each of the known cell types. The suffix s and t denotes the simulated
and true distributions. The plot demonstrates that the simulated distributions closely
resemble the true distributions.
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the canonical cell type signature is required as input. Therefore only the unsupervised
methods DSA [112], Deconf [86] and the semi-supervised NMF based methods SSKL,
FROB [30, 29] are compared against our single cell quadratic programming based
method denoted UCQP. The semi-supervised methods are given the opportunity to
mine the single cell data to build the descriptive signatures necessary using tools built
into the CellMix toolkit [30].

3.4.2

Experimental parameters

This work will compare the effect of several experimental parameters across the different deconvolution methods. One of the primary parameters explored is the number
of mixtures measured in order to determine the effect of this parameter on accuracy.
The error parameter is also varied to compare methods at varying degrees of difficulty,
finally the number of genes used in the deconvolution is varied.

3.4.3

Mixture effects

One important dimension to this single cell aided deconvolution formulation is the
number of mixtures necessary to properly deconvolve the system. Since both single
cell and bulk qPCR data is necessary it is important that the number of mixtures
required be kept small to contain costs. To this end several simulations were carried
out where the number of mixtures is varied in the set 5, 10, 15, 20, 25, 30.
Under the “ideal” scenario seen in figure 3-2a, the number of genes is fixed to
32, the error is set to 40 samples per cell, and the concentration is uniform across
all mixtures. There is no absolute pattern or correlation between accuracy as the
number of mixtures varies for any of the methods. The UCQP method outperforms
both the semi and unsupervised methods.
In figure 3-2b the error and gene count is at 40 and 32 respectively, however the
concentrations are random. There is again an absence of any connection between
rmse as the number of mixture varies. The absolute rmse for DECONF, SSKL suffers
slightly, UCQP remains the same and interestingly DSA, the unsupervised method,
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improves dramatically.
The final comparison in figure 3-2c fixes the error at 40 and the concentrations
are uniform. Here the number of genes is halved from 32 to 16. The absolute rmse
for all methods seems to suffer little, with a possible anti correlation between mixture
count and accuracy observed for DECONF.
The number of mixtures used in deconvolution is a critical parameter as it influences the cost and feasibility of collecting the appropriate amount of data. Finding an
algorithm which works well with a minimum number of mixtures necessary makes insilico deconvolution more attractive. The UCQP approach presented here performs
deconvolution one mixture at a time and therefore no constraints on the number
of mixtures exist. It follows that the accuracy of UCQP should be independent of
the number of mixtures. This was observed in 3-2. It should also be the case that
DECONF, SSKL and DSA all have some dependency on the number of mixtures.
However, only a minimal dependency is observed in figure 3-2.

3.4.4

Error effects

It is important to quantify the ability of the deconvolution algorithm as the level of
error changes. In the following simulation experiment the error parameter was varied
between 5,20,40 and 100.
The ideal scenario has the number genes is fixed to 30, there are 10 mixtures and
equal concentrations set across cell types. In figure 3-3a the accuracy of UCQP has a
direct correlation with the error parameter. At 5 samples per mixture the algorithm
performs worst and at 100 it has significantly lower error. The DECONF and DSA
algorithms do not seem to have a clear relationship between error and accuracy and
SSKL is not effected at all.
In figure 3-3b the number of mixtures is 10, gene count is 32 and the concentration
is random. Both the UCQP and DSA algorithms have a direct correlation with the
error parameter and rmse. The absolute rmse for UCQP is best for all scenarios.
In the last comparison in figure 3-3c the number of mixtures and gene count are
10 and 16, respectively, while the concentration is uniform. The results are almost
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(a) Mixture Effect: Ideal Scenario

(b) Mixture Effect: Random Concentration

(c) Mixture Effect: 16 Genes

Figure 3-2: In this figure the accuracy of the 5 deconvolution methods in estimating
the concentration matrix is compared using rmse metric. Each method is evaluated
given a different number of mixtures between 5 and 25. In general no method has a
strong correlation to the number of mixtures.
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exactly the same as the ideal scenario in figure 3-3a.
The proposed error model is quite simplistic and conflates both technical and biological noise. However without a stronger understanding of both the technical and
biological sources a more advanced model may be premature. Adjusting the number
of sampled single-cells to create each mixture enables the simulation to create easy
scenarios, where each cell type is sampled sufficiently to get close to the canonical
average, and more difficult instances where each cell type is far from the average.
Additionally since this approach relies on sampling, it will inherently reflect the biological diversity of the supplied single-cells. If each cell population is quite diverse,
more sampling will be required to find the average and therefore accurate deconvolution will be more difficult.
The error effects are most dramatic in 3-3b where the mixtures consist of random
concentrations of each cell type. Intuitively this scenario seems the most challenging
with respect to inferring cell type concentration and it seems natural that increased
error makes the problem more challenging. Both UCQP and DCA improve as the
sampling rate is increased, while the NMF methods do not respond as clearly. No
explanation for these effect is immediately apparent. One advantage of the simpler
quadratic programming based method is that understanding effects becomes easier.

3.4.5

Gene effects

The number of genes necessary to measure is an important parameter for this approach. Therefore a wide range of gene counts were surveyed in order to asses the
effect across a variety of methods for qPCR. Values of 8, 16, 32, 64, 128 and 256
were tested. The genes were not selected at random, but rather were ranked using
ANOVA test, excluding the lower scoring genes first.
In the ideal scenario depicted in figure 3-4a the error parameter is 40, concentrations are uniform and the number of mixtures is fixed at 5. Here UCQP outperforms
all methods in terms of mean absolute error. There is a clear inverse relationship
between the number of genes used and error in UCQP. No other method has this
clear relationship.
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(a) Error Effect: Ideal Scenario

(b) Error Effect: Random Concentration

(c) Error Effect: 16 Genes

Figure 3-3: In this figure the accuracy of the 5 deconvolution methods in estimating
the concentration matrix is compared using rmse metric. Each method is evaluated
given a different error level between mixtures between 5 and 100.
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Figure 3-4b has the error fixed at 40, mixtures 5 and the concentrations are
random. For UCQP this more challenging scenario has no noticeable effect on mean
absolute error. There is still a clear inverse relationship between gene count and error
for UCQP and no relationship for other methods.
The final scenario in figure 3-4c fixes the number of mixtures to 5, the concentrations are uniform but the error parameter is set to 5. Here the high error rate clearly
changes the absolute error of UCQP, however the inverse relationship between gene
count and error rate still exists.
When considering just the UCQP method in figure 3-4 the effect of number of
genes is quite clear. There exists a saturation point where the accuracy of the estimates no longer improves when adding more genes. This behavior is not observed in
any of the other approaches. It should be noted that this simulation does not start
with a random subset of genes, in fact all genes used in the data behind the simulation
were chosen by domain experts. Also it is interesting to note that a high degree of
accuracy can be obtained by using as few as 16 genes.

3.4.6

Missing Cell Type

Simultaneously estimating the canonical gene expression signature for a missing cell
type and the concentrations of all cells is a difficult challenge. In order to test the
proposed non-linear optimization approach a basic leave-one-out scenario was utilized.
In this testing setup, each cell type was left out and its signature was estimated using
the presented approach (UCQPM) compared against DECONF which can be told to
estimate all cell types. As before, this scenario was repeated 10 times and the following
results are the average of the 10 replicates. A second study our basic model used to
detect if a cell type is missing or not. This was presented as a binary classification
problem and assessed accordingly.
In general the UCQPM method outperforms unsupervised deconvolution on all of
these missing cell type experiments. The results for these experiments are detailed in
figures 3-5 and 3-6. This holds for all tested conditions.
In figure 3-5 the mixture effect is measured. There is a an inverse relationship
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(a) Gene Effect: Ideal Scenario

(b) Gene Effect: Random Concentration

(c) Gene Effect: High Error

Figure 3-4: In this figure the accuracy of the 4 deconvolution methods in estimating
the concentration matrix is compared using rmse metric. Each method is evaluated
given a different gene count between 8 and 256.
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Figure 3-5: This graph has two y-axis, the left describes the mean absolute error of the
signature estimate (solid line), while the right indicates the rmse of the concentration
estimate (dotted line). The number of mixtures is fixed to 5, the error parameter is
100 and the concentrations are random. The x-axis varies the number of mixtures.
between both the concentration and signature estimates and error for UCQMP. This
is consistent with results observed in the non-missing scenario. For DECONF no such
consistent relationship is observed.
Figure 3-6 details the effect of noise on missing cell type estimates. The number
of mixtures is fixed to 20, the concentration is random, and 64 genes are used. For
UCQPM there is a clear inverse relationship between error and accuracy. At a high
error rate (5 cells per type), both the signatures and concentrations are estimated
poorly. As the error parameter increases the mean absolute error and rmse decreases
which is also reflected in the non-missing scenario.
The final test evaluates our basic predictor of a missing cell type. The algorithm
applies both missing and non-missing approaches to a given deconvolution problem,
then applies the basic test 𝑟ˆ > 𝑟 + 𝛾 where 𝛾 is some small constant. Where 𝑟ˆ
is the residual calculated assuming a missing cell type, 𝑟 is without a missing cell
type. This scenario was tested by creating 10 mixtures with a missing cell type and
10 without. Both UCQPM and UCQP were run on each dataset and the test was
applied predicting if it contained a missing cell type. This whole scenario was repeated
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Figure 3-6: This graph has two y-axis, the left describes the mean absolute error of the
signature estimate (solid line), while the right indicates the rmse of the concentration
estimate (dotted line). The number of mixtures is fixed to 20, the gene count is 64,
concentrations are random. The x-axis varies the error parameter.
10 times with the average results displayed in table 3.1.
error
70
80
90
100

accuracy
0.77
0.72
0.72
0.77

AUC
0.89
0.86
0.84
0.81

Table 3.1: This table records the binary classification problem attempting to predict
the presence of a missing cell type from single cell and bulk qPCR data. There
error column indicates the error parameter used in the simulation (higher being lower
noise). The accuracy column is the typical notion of accuracy, and AUC is the areaunder-curve.
In general this leave-one-out experiments indicates that UCQPM provides a more
robust estimate of the missing cell type signature and concentrations than the unsupervised approach. This results is expected because the UCQPM utilizes more
information about the system and is estimating a smaller number of variables . The
quadratic programming formulation allows the method to be tailored to any number
of unique situations, maximizing the use of available information.
However the ability of our simple threshold method to detect a missing cell type
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leaves much room for improvement. The best accuracy observed in this ideal experiment is 0.89 AUC as seen in table 3.1. Clearly this simplistic model will not be
scalable to more complex scenarios where more than 1 cell type is missing. Alternative
approaches will need to be explored.

3.5

Conclusions

This work presented an in silico gene expression deconvolution and missing cell type
detection algorithm which is based on quadratic programming. This supervised approach relies on single cell resolution data to estimate cell type signatures, then uses a
well defined non-negative least squares objective to estimate cell type concentrations.
This approach was compared against leading semi-supervised and unsupervised NMF
based methods and was shown to perform well. Estimating a missing cell type signature is also possible using a basic quadratic programming formulation. The signature
and concentration estimation accuracy is much better than completely unsupervised
NMF based methods. A basic approach to detecting a missing cell type was presented,
however it is likely to be insufficient in more complex scenarios.

79

80

Chapter 4
Conclusions
The common theme in this work has been to find an elegant way of adopting computationally intensive optimization algorithms to solve problems unique to highthroughput genomics research. This final chapter summarizes the presented problems
and strategies used to solve them. For each problem the current state of the art is
discussed and potential future work proposed. Although only three problems and
three strategies are discussed, the presented themes may aide others searching to find
that edge necessary to solve their particular challenge.

4.1

Genome scaffolding

While genome assembly and scaffolding has always been a challenging task, this
challenge has been exacerbated by the proliferation of sequencing technologies and
the ensuing reduction in cost of whole genome sequencing. One part of a practical
genome assembly is imparting order and orientation on contigs, a process known as
scaffolding. The presented solution leverages the fixed-width nature of the scaffolding
graph in conjunction with the ILP scaling technique NSDP in order to efficiently
compute the best scaffolding with few compromises.
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Assumptions and limitations
The scaffolding problem itself has only recently re-emerged as a relevant problem. As
the human genome project neared completion scaffolding was formalized by Huson et.
al. [47] in response the practical need of having to orient and organize the disparate
contigs comprising the human genome. In this earlier context the technology available,
Sanger sequencing, produced reads exceeding 1000 bases in length, forming large
contigs. The paired reads were also fewer in number and due to their length aligned
with less ambiguity. However the trend towards shorter contigs assembled from short
reads has made the problem more difficult.

Figure 4-1: This plot indicates the expected upperbound on the scaffolding graph
bandwidth for various minimum contig sizes and paired end library insert sizes. The
x-axis indicates minimum contig size, up to 20k bases, and the y-axis is the graph
𝑡
bandwidth upperbound computed by 𝑤 ≤
where 𝑤 is the graph bandwidth, 𝑡 is
𝑙𝑚𝑖𝑛
the insert size and 𝑙𝑚𝑖𝑛 is the minimum contig size. There are four series representing
different minimum contig sizes.
Work in [26] made the observation that the scaffolding graph should have some
special properties. Namely that the number of contigs which can be adjacent to any
given contig is bounded by the maximum insert size of the paired end library. The
82

cited formula 𝑤 ≤

𝑡

from [95] indicates that in the ideal scenario the number of
𝑙𝑚𝑖𝑛
contigs is quite small. A graph representing a reasonable range of values can be see
in Figure 4-1. This assumption, along with the presence of large fence [26] contigs
bolsters the argument that the scaffolding graph can be decomposed into sufficiently
small components solvable using NSDP.
While very promising, this assumption that the scaffolding graph has a fixed
bandwidth fails in practice due to errors in the read alignment. The high repeat
content of genomes causes increased assembly and read alignment errors. These
errors significantly increase the number of possible adjacent contigs and thus make
decomposition difficult.

State of the art and community work
The process of scaffolding fragments of a draft genome does not always rely solely
on paired-end sequencing data. Recent work in [16, 91] explored the use of Hi-C or
optical restriction maps to provide chromosome scale linkage information. These new
techniques combine both paired-end sequencing containing short range information
with the long range information to give a much more comprehensive scaffold. The
combination of these two data types is often done in a hierarchical manner, first
scaffolding on small or large scale then increasing or decreasing the resolution similar
to [52].

Future work
Genome scaffolding will always be part of de novo genome assembly although the
difficult of the problem may diminish as technology improves. Read lengths on NGS
sequencers are again approaching several hundred base pairs, which improves both
the contig assembly accuracy and the reliability of paired-read alignments. A recent publication [108] demonstrated the use of a basic k-mer counting algorithm for
scaffolding using 1000 bp plus strobed reads from the Oxford Nanopore sequencer.
Additionally the sheer volume of reads produced from traditional NGS sequencers,
83

combined with more scalable and accurate genome assembly algorithms will again
enable basic bundle size filtering [47].
An interesting application of de novo sequencing, and by extension scaffolding is
the detection of structural variation (SV) [59]. The idea behind this work is that read
alignment based approaches are inherently biased towards pre-programmed structural
variations. Existing work performs complete de novo assembly, performs traditional
SV detection, and uses an alignment based comparison of the assembled genome
versus a reference for further evidence. While feasible, the cost of acquiring high
coverage sequencing for de novo assembly still remains quite expensive. There may
be an opportunity to utilize an ILP formulation similar to that used in SILP2 to
detect certain structural variations. The high-level approach would be:
∙ align paired reads from subject as singletons against reference genome
∙ randomly fragment reference genome into pseudo-contigs
∙ construct scaffolding graph from paired end linkage information
∙ solve optimal orientation of pseudo-contigs
In this approach inversions would be detected when a pseudo-contig is flipped, since
the contigs are known to originate from state A. Additional structural variation events
could be detected by augmenting the ILP formulation.

4.2

Biomarker selection and predictive modeling

The process of biomarker selection is an extremely important step in translating
genetic discovery to actionable medicine. It is also an active area of research, with
many techniques being published. The work presented here provides an easy-touse approach to survey all biomarker selection and classification algorithms to build
the most accurate predictive model. The approach utilizes standard nested crossvalidation techniques but has implemented them in a scalable cloud based architecture
which relies on distributed task queues.
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Assumptions and limitations
The main premise utilized in our pipeline is utilize extensive parametrization and
large scale surveys to find optimal feature selection algorithm and build the best
predictive models. Although somewhat simplistic in theory this strategy was proven
to be quite effective in practice. However there are several areas where simplifying
assumptions were made to make the strategy practical:
∙ normalization and scaling
∙ ignoring co-variance
∙ aggregate features
The notion of normalization and scaling is critical to building predictive models.
Correction for technical and measurement noise can greatly improve performance and
every algorithm is tuned to work in a specific numerical range. The presented work
does not address normalization strategies which can be quite diverse, although the
paradigm can be easily extended to accommodate them. Another simplification made
was to ignore the co-variance between features when computing the optimal biomarker
set. For some application, markers with strong co-variance may not be desirable.
Finally recent advances in deep-learning and knowledge based feature selection have
demonstrated the power of aggregate features, or feature sets. Here two or more
genes are considered simultaneously or mathematically convolved into a single pseudo
feature which can be more powerful.

State of the art and community work
Advances in predictive modeling and feature selection have been occurring at breakneck speed. Driving much of the cutting edge research are the fields of computervision and so called deep-learning. These techniques are making their way into the
bioinformatics domain [110] with amazing results.
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Future work

The modular nature of the parametrization and model selection pipeline enables easy
integration of new approaches as they are published. Furthermore, the paradigm
introduced in this work to solve the biomarker selection problem can be generalized
to solve a variety of other problems. One such problem is dimension reduction and
visualization of gene expression data.
There are numerous methodologies for clustering single cell gene expression profiles into cell types. One strategy is to enumerate each of the leading techniques
and evaluate them using a variety of criteria as seen in Figure 4-2. This procedure
enables the biologist to compare criteria and make an informed decision around the
appropriate clustering procedure. This approach is an extension of existing ensemble
and survey methodologies [22] made possible by a highly engineered cloud computing
environment.
For dimension reduction we will test manifold learning methods (spectral embedding, t-SNE, linear embedding), PCA, sparsePCA, factor analysis and NMF. Several
common clustering algorithms including affinity propagation, mean shift, spectral
clustering, db scan and k-mean clustering as well as metrics such as silhouette score,
gap statistic, Davies-Boulden, homogeneity index, separation index or some combination of these will also be tested. Often only intuition or experience is used to
inform the method selection and parametrization. Rather than rely on intuition, our
approach is to test each model against the others using several objective functions,
allowing the most appropriate model for a particular dataset to be automatically
selected. After global normalization of mean expression profiles, matching clustered
single cell expression profiles to known cell type expression profiles will be done based
on similarity measures selected via cross-validation experiments among both standard
measures such as Pearson correlation and pathway-based similarity measures such as
attract [69].
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4.3

Single-cell assisted deconvolution

Single cell gene expression profiling is becoming widely accessible thanks to the proliferation of advanced sample preparation microfluidic equipment and protocols. Preliminary work has shown expression profiles at this resolution is quite different than
bulk level gene expression. In order to bridge this gap we have proposed a novel usage of gene expression deconvolution using quadratic programming techniques. The
effort presented here is still very much work in progress. The framework is still under
development and requires extensive validation on biological datasets.

Assumptions and limitations
The primary assumption made in this work is that the researcher has the ability
to cluster individual single cell expression profiles into meaningful clusters which
accurately represent the constituent cell types. This assumption may necessitate
sampling a very large number of single-cell data points. Cell-cycle effects may further
result in a broad range of gene expression values for cells sampled from a single
phenotypic cell type.

State of the art and community work
There have been many pioneering efforts to build solutions and techniques for dealing with the unique challenges found in single-cell analysis. For example a recent
study explored techniques [15] for removing cell cycle effects when studying singlecells across multiple conditions. This can allow for better biomarkers selection and
potentially yield better automated clustering.
Many groups are also investigating advanced dimension reduction and clustering
[90, 101] which are more appropriate for the single-cell domain. Others are exploring
lineage inference techniques [107, 70] where gene expression profiles are compared and
ordered according to various objectives, or they are physically collected at different
time points. The developmental lineage can then be computationally inferred using
a variety of approaches.
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Future work
While a universally agreed upon definition of what constitutes a cell type is still lacking, curating and organizing single cell, cell line, and bulk tissue expression data into
a database of canonical cell type expression profiles can greatly simplify future gene
expression studies. Establishing such a database would not only serve as a repository
for single cell data, but, by accepting cell line and bulk mixtures (coupled with deconvolution), would allow it to become a unified source to cell type definitions. Below
we describe a customizable and modular strategy for establishing such a database,
called Cell Type DB. The database is composed of 3 distinct layers as illustrated in
Figure 5: the raw expression layer, an organization layer, and finally an aggregation
to cell type layer.
The raw gene expression layer accepts 3 types of data, single cell gene expression,
cell line gene expression and finally bulk (heterogeneous mixtures) gene expression.
Data which is pre-processed by an external party will be required to be normalized according to best practices and to account for batch effects. Datasets which
are deposited directly, such as new bulk or single cell data can be pre-processed directly. This layer will likely be implemented using Apache HBase which provides
excellent real-time /read/write access to data tables consisting of millions of columns
(genes/isoforms) by billions of rows (gene expression profiles).
The organization layer’s primary purpose is to stratify each individual gene expression profile into clusters corresponding to cell type, and then convert each cluster
into a canonical expression profile. The procedure for this is different for each data
type; single cell will be processed using the typical clustering methodologies, cell
line data is highly homogeneous and require minimal preprocessing, while bulk data
will be computationally deconvolved into its constituent cell types. This layer will
be implemented in MongoDB, a NoSQL DB which excels at storing semi-structured
data.
The final aggregation layer will consist of the computed cell type expression profiles. A query will consist of two components; the raw expression profiles to start
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with, the organization strategy. This module access layer enables the database to
support multiple, well defined strategies for defining a cell type.

4.4

Closing

The cat-and-mouse game between bioinformatics and problem size driven by the
state-of-the art biotechnology platforms will continue. Fortunately, as the cost of
data acquisition drops, so too does the cost of computing resources. Although researchers will always be looking to improve the theoretical approaches to solving
large scale optimization problems, there is still substantial opportunity to implement
practical solutions. The common themes in these solutions will be leveraging powerful
distributed computing resources and alternative problem formulations which better
approximate the underlying biological systems.
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Figure 4-2: This algorithm tests all combinations of dimension reduction and clustering algorithms to find the approach which provides the optimal results.
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Figure 4-3: Cell Type DB provides a dynamic mechanism for storing and accessing
canonical cell type expression profiles. Like a in a traditional database the first
layer stores the raw single cell gene expression data. The middle layer is the cell
annotation where one or more of the single cells are annotated according to the
clustering methodologies or external mechanisms, the final layer applies a procedure
to aggregate the single cell clusters into the canonical cell type expression profile.
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